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Abstract
Aging is a multifactorial process resulting in several functional and esthetic changes in the skin. Advances in research have 
yielded a tremendous amount of  information on the molecular pathways involved in both intrinsic aging (natural) and extrin-
sic aging (including photoaging). Some of  the characteristic features of  aging skin, such as wrinkling, loss of  elasticity, and 
atrophy, can largely be attributed to dermal changes. The amount of  collagen in the skin decreases, while the cross linking 
increases, and the solubility of  collagen is reduced. The role of  fibroblasts in aging tissue has been most extensively studied in 
mammalian skin. The total number of  fibroblasts decreases, and their metabolism shows characteristic alterations.The dermis 
is maintained in large part by fibroblasts, which secrete dermal collagens, elastin, and other extracellular matrix components. 
When the skin is wounded, fibroblasts secrete proteases to degrade the wounded matrix, and then synthesize new matrix. The 
fibroblasts also secrete growth factors to stimulate the keratinocytes to proliferate and close the wound and cytokines to attract 
macrophages to engulf  and degrade debris. Stress-induced premature senescence (SIPS) occurs after many different sublethal 
stresses including a number of  oxidation factors, such as H2O2, hyperoxia, or organic and lipid hydroperoxides. Fibroblast cells 
in replicative senescence share common features with cells in SIPS: morphology, senescence-associated beta-galactosidase ac-
tivity, cell cycle regulation, gene expression and telomere shortening. Most human cells lack sufficient telomerase to maintain 
telomeres, hence these genetic elements shorten with time and stress, contributing to aging and disease. We systematically 
examine the evidence supporting the use of  dosage forms of  non-hydrolized carnosine or carcinine in oral formulations for 
skin beautification purposes and provide a summary of  the biomarkers of  intrinsic and extrinsic skin aging, including pho-
toaging. Senescence phenotype of  human diploid fibroblasts is related with the exhaustion of  their proliferative potential. 
This work suggests that different cell types, such as human skin fibroblasts, may use specific cellular treatment strategies with 
imidazole-containing dipeptides to halt the accelerated senescence of  the fibroblast cells in response to telomere attrition and 
thus prevent skin aging through the number of  biologically viable and safe metabolic pathways. The published data demon-
strate that telomerase is expressed in the epidermis in situ independent of  age. The reason for the sustained telomere length 
or expression of  telomerase activity in the epidermis is associated not only with an increased turnover of  keratinocytes, but 
also occurs due to the fact that the formation of  a well structured epidermis strictly depends on a tight balance between pro-
liferation and differentiation. Oral dosage forms of  non-hydrolized carnosine or carcinine induce cellular responses in human 
skin fibroblasts through the telomere-mediated pathway and redox signaling, supporting the view that carnosine or related 
imidazole-containing dipeptide based compound-induced hormetic stimulation of  cellular antioxidant defenses can be a use-
ful approach toward anti-aging intervention to the skin.
      Keywords: Skin Aging; Intrinsic Aging, Extrinsic Aging And Photoaging; Telomeres And Telomerase Biology; Epidermis, 
      Skin Fibroblasts; Healthy Aging, Age-Related Diseases; Natural Imidazole-Containing Peptidomimetics; Oral Dosage Forms of  
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Introduction
Aging is a multifactorial process resulting in several functional and 
esthetic changes in the skin. Recent advances in skin biology have 
increased our understanding of  skin homeostasis and the aging 
process, as well as the mechanisms by which ultraviolet radiation 
contributes to photoaging and cutaneous disease. These advances 
in skin biology have led to the development of  a diversity of  treat-
ments aimed at preventing aging and rejuvenating the skin [1]. 
The quest for youth and beauty of  the skin is an ongoing one. In 
developed countries, interest in cutaneous aging is in large part 
the result of  a progressive, dramatic rise over the past century in 
the absolute number and proportion of  the population who are 
elderly. Young skin is characterized by thick epidermal and der-
mal layers and relatively efficient wound healing. The epidermis 
contains numerous invaginations, or rete ridges, and the dermis 
contains dense collagen. 
Old skin, by contrast, is characterized by a thinner epidermis that 
contains fewer and shallower rete ridges. The dermis also be-
comes thinner, showing a marked loss of  collagen and other fib-
ers. Changes in the dermis are in large measure responsible for the 
loss of  elasticity and wrinkling that is the hallmark of  aging skin. 
In addition, wound healing slows with age. Aging is particularly 
sensitive to environmental influence in the skin: skin exposed to 
the sun (ultraviolet light) ages much more rapidly than sun-pro-
tected skin.
The aging and its effects on the skin in older persons have created 
a demand for a better understanding of  the aging process and 
particularly for effective therapeutic interventions for better skin 
beautification and rejuvenation. Skin aging and longevity regula-
tion are complex processes determined by the genetic endow-
ment of  the individual and by environmental factors. 
The appearance of  old skin and the clinical consequences of  skin 
aging have been well known for centuries, but it is only in the 
past 50 years that mechanisms and mediators have been pursued 
systematically. Still, within a relatively short time, there has been 
tremendous progress, a progress greatly enhanced by basic ger-
ontologic research using immunologic, biochemical, cellular and 
in particular, molecular biologic techniques [2]. An impressive 
amount of  basic science and clinical research has been conducted 
in both an attempt to discover novel strategies for preventing det-
rimental sun damage and to validate the addition of  novel oral 
antioxidant formulations to skin care products. As dermatolo-
gists, it will be essential to provide our patients with substantiated 
counseling regarding the efficacy of  commercial assertions. The 
average age of  people has been increasing over the years, trigger-
ing more awareness and more interest in the study of  regenerative 
medicine, especially degeneration of  the skin which is an organ 
that is crucial noticeably for appearance.
In this review, we will systematically examine the evidence sup-
porting the use of  patented dosage forms of  non-hydrolized car-
nosine or carcinine in oral formulations for skin beautification 
purposes and provide a summary of  the pathogenesis of  intrinsic 
and extrinsic skin aging , involved factors of  aging and photoag-
ing. This review article suggests that different cell types , such as 
human skin fibroblasts may use specific cellular treatment strate-
gies with imidazole-containing dipeptides to halt the accelerated 
senescence of  the fibroblast cells in response to telomere attrition 
and thus prevent skin aging through the number of  metabolic 
pathways. This may be attributed to the distinct senescent pheno-
typic characteristics of  the resident skin fibroblasts. The results 
suggest that ectopic expression of  hTERT, in addition to acting 
in telomere length maintenance by safe activating telomerase with 
imidazole-containing dipeptide(s), also functions in regulating se-
nescence induction.
The Central Role of  Fibroblast Cells Physiologi-
cal Changes in Aging Skin Stroma
Skin aging is the multifactorial process both internal and external 
factors, such as, age, sex, race, disease of  internal organs and envi-
ronmental exposure. However, the main causes of  skin degenera-
tion are heredity and sunlight. The latter induces the most skin 
degeneration. Thus far, many studies have been conducted on 
pathogenesis and prevention of  Photo-aging, as well as regenera-
tion of  damaged skin [3-8]. The role of  fibroblasts in aging tissue 
has been most extensively studied in mammalian skin. The skin is 
composed of  two primary layers: the epidermis, which contains 
the major epithelial cells of  the skin (epidermal keratinocytes), 
and the dermis, which is the stromal layer of  the skin (Figure 
1, Tables 1, 2). As with other stroma, the dermis is maintained 
in large part by fibroblasts, which secrete dermal collagens, elas-
tin, and other extracellular matrix components. When the skin is 
wounded, fibroblasts secrete proteases to degrade the wounded 
matrix, and then synthesize new matrix. The fibroblasts also se-
crete growth factors to stimulate the keratinocytes to proliferate 
and close the wound and cytokines to attract macrophages to en-
gulf  and degrade debris [9].
The life history of  fibroblast and fibroblast-like cells includes an 
initial stage of  outgrowth and establishment in culture; a period 
of  vigorous proliferation which has a variable length, depending 
on the tissue of  origin, age of  the donor, etc.; a period of  de-
clining proliferative vigor which includes substantial cell death; 
and finally, the emergence of  an (apparently) long-lived popula-
tion which is unable to proliferate in response to growth factors. 
The research in this area began with a detailed characterization 
and comparison of  young versus senescent cell morphology and 
physiology. These studies provided the basis for a wide variety 
of  subsequent studies that addressed possible mechanisms un-
derlying cell senescence. These included studies on DNA repair, 
protein synthetic errors, chromatin structure and function, and 
mechanisms for modulating replicative life span (reviewed in ref. 
[10]). Senescent fibroblasts appear to increase with age in hu-
man dermis, and senescent fibroblasts constitutively secrete fac-
tors that, ordinarily, are secreted only transiently during wound 
healing [10, 11]. These factors include interstitial collagenase and 
elastase, which are matrix metalloproteinases that degrade dermal 
collagens and elastin. Ultraviolet light can also induce these metal-
loproteinases, as well as cellular senescence, in fibroblasts. Thus, 
some of  the hallmarks of  aging skin, such as wrinking and loss of  
dermal elasticity, are likely due, at least in part, to the secretion of  
metalloproteinases by fibroblasts, which, in turn, may be due to 
cellular senescence and/or environmental exposure to ultraviolet 
light.
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Figure 1. Functional and Morphological Elements and Layers of  the Skin.
(A)
A. The stratum corneum ("the horny layer") is the outermost layer of  the epidermis (the outermost layer of  the skin). It is composed 
mainly of  dead cells that lack nuclei. As these dead cells slough off, they are continuously replaced by new cells from the stratum germina-
tivum (basale). In the human forearm, for example, about 1300 cells/cm2/hr are shed and commonly accumulate as house dust. Cells of  
the stratum corneum contain keratin, a protein that helps keep the skin hydrated by preventing moisture evaporation. In addition, these 
cells can also absorb moisture, further aiding in hydration and explaining why humans and other animals experience wrinkling of  the skin.
Keratinocyte is the major cell type of  the epidermis, making up about 90% of  epidermal cells. The epidermis is divided into four or five 
layers (depending on skin type) based on keratinocyte morphology:
• Stratum basale (at the junction with the dermis)
• Stratum spinosum
• Stratum granulosum
• Stratum lucidum (only present in thick skin - i.e. palms of  hand and soles of  feet)
• Stratum corneum
Keratinocytes originate in the basal layer from the division of  keratinocyte stem cells. They are pushed up through the layers of  the epi-
dermis, undergoing gradual differentiation until they reach the stratum corneum where they form a layer of  enucleated, flattened, highly 
keratinized cells called squamous cells. This layer forms an effective barrier to the entry of  foreign matter and infectious agents into the 
body and minimises moisture loss.
Taking non-hydrolized imidazole-containing dipeptide based antioxidant oral supplements can help enhance the skin’s natural protective 
properties (see below) as well as having beautifying properties.
Skin is composed of  the dermis and epidermis - each with unique components and functions. Contained within each layer are mixtures 
of  cells and connective tissue that provide form and function for the skin (Figure 1). More specifically, keratinocytes, which produce kera-
tin to harden and waterproof  the skin, can be found in the epidermal layer. Melanocytes, which produce melanin, provide pigmentation 
for both hair and skin, deliver protection from UV radiation, and are found in fewer numbers in the dermal layer. Melanocytes intercalate 
up into the epidermis and establish close and critical interactions with keratinocytes to perform various cellular functions during develop-
ment and normal maintenance of  the skin. Healthy skin also contains a number of  other structural elements, including collagen fibers 
and fibroblasts located in the basement membrane, lending strength and structure to the skin. Layered within the basement membrane 
matrix are dermal microvasculature and lymphatic vessels for blood circulation and waste removal, vital to proper skin function. 
Normal skin is shown with the key epidermal and dermal elements. The epidermis contains the dividing epithelial cells at the basement 
membrane migrating to the surface forming keratinocytes and maintaining the surface barrier. The basement membrane, rich in adher-
ence proteins, anchors the epithelial cell layer. The dermis is made of  components produced by fibroblasts, including collagen (mostly 
type I), glycosaminoglycans, and other matrix proteins.
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A major factor that determines the appearance of  the skin is the 
condition of  the dermal collagen. Although there are differences 
between young and aged skin with respect to the condition of  
the epidermis, dermal collagen is the most important factor in 
whether the skin appears to be young or old [12]. Some of  the 
characteristic features of  aging skin, such as wrinkling, loss of  
elasticity, and atrophy, can largely be attributed to dermal changes. 
The amount of  collagen in the skin decreases, while the cross 
linking increases, and the solubility of  collagen is reduced. The to-
tal number of  fibroblasts decreases, and their metabolism shows 
characteristic alterations. Some of  the functions of  fibroblasts in 
aging skin, such as the synthesis of  protein and collagen, but also 
proliferation and chemotaxis, can be investigated by means of  in 
vitro models. In addition, various syndromes of  premature aging 
(e.g. progeria, Werner's syndrome) have proved useful models 
and have contributed considerably to the understanding of  aging 
processes [13]. On a molecular level, UV radiation from the sun 
attacks keratinocytes and fibroblasts, resulting in the activation of  
cell surface receptors, which initiate signal transduction cascades. 














B. The cross section of  normal skin demonstrates the key components. Keratin, a product of  keratinocytes, resides on the outer most 
surface. Keratinocytes (epithelial cells) make up the first or outer layer of  skin, i.e. the epidermis. Note that keratinocytes can also be seen 
in the cross sections of  hair follicles found in the dermis. The dermal layer is composed of  collagen seen as swirls of  pink material. The 
lighter pink homogenous material is made up of  glycosaminoglycans and other compounds produced by the fibroblasts (elongated dark 
cells) such as fibronectin and hyaluronic acid. 
Dermis: 
Protection from trauma due to the dermal properties of  elasticity and durability.
Fluid balance through regulation of  skin blood flow.
Thermoregulation through control of  skin blood flow. 
Growth factors and contact direction for epidermal replication and dermal repair.
(B)
(C)
C. Healthy human fibroblasts
Simultaneously dermal activity stimulates the skin’s fibroblasts to increase collagen replenishment to strengthen and rejuvenate skin for 
a smoother, tighter, more contoured appearance.
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a breakdown of  collagen in the extracellular matrix and a shut-
down of  new collagen synthesis [14]. Research on fibroblast bi-
ology in three-dimensional collagen matrices offers new oppor-
tunities to understand the reciprocal and adaptive interactions 
that occur between cells and surrounding matrix in a tissue-like 
environment. Such interactions are integral to the regulation of  
connective tissue morphogenesis and dynamics that characterizes 
tissue homeostasis and wound repair. During fibroblast collagen 
matrix remodeling, mechanical signals from the remodeled matrix 
feed back to modulate cell behavior in an iterative process. As me-
chanical loading (tension) within the matrix increases, the mecha-
nisms used by cells to remodel the matrix change. Fibroblasts in 
matrices that are under tension or relaxed respond differently to 
growth factor stimulation, and switching between mechanically 
loaded and unloaded conditions influences whether cells acquire 
proliferative/biosynthetic active or quiescent/resting phenotypes 
[15].
Another feature of  aged skin is fragmentation of  the dermal 
collagen matrix. Fragmentation results from actions of  specific 
enzymes (matrix metalloproteinases) and impairs the structural 
integrity of  the dermis. Several of  metalloproteinases, as for in-
stance MMP-2 and MMP-9 among others also act on elastic fibers 
(reviewed in ref. [16]). Fibroblasts that produce and organize the 
collagen matrix cannot attach to fragmented collagen. Loss of  
attachment prevents fibroblasts from receiving mechanical infor-
mation from their support, and they collapse. Stretch is critical for 
normal balanced production of  collagen and collagen-degrading 
enzymes. In aged skin, collapsed fibroblasts produce low levels of  
collagen and high levels of  collagen-degrading enzymes. This im-
balance advances the aging process in a self-perpetuating, never-
ending deleterious cycle. Clinically proven anti-aging treatments 
such as topical retinoic acid, carbon dioxide laser resurfacing, and 
intradermal injection of  cross-linked hyaluronic acid stimulate 
production of  new, undamaged collagen. Attachment of  fibro-
blasts to this new collagen allows stretch, which in turn balances 
collagen production and degradation and thereby slows the ag-
ing process. Collagen fragmentation is responsible for loss of  
structural integrity and impairment of  fibroblast function in aged 
human skin. Treatments that stimulate production of  new, non-
fragmented collagen should provide substantial improvement to 
the appearance and health of  aged skin (reviewed in ref. [16]).
The dermal extracellular matrix among the other molecular con-
stituents is composed of  type I collagen, proteoglycans, and gly-
cosaminoglycans produced and secreted by fibroblasts. Type I 
collagen is the most abundant protein in the dermal extracellular 
matrix. It is responsible for the support and structure of  the skin, 
and its loss and degradation are thought to result in the clini-
cal phenotype of  aged skin, specifically with regard to fine and 
Table 1. Characteristics of  the Skin Layers.
Epidermis – The outer thinner layer known as the epidermis is composed mainly of  epithelial cells. The outermost cells 
contain the tough protein keratin and are known as keratinocytes. The basal or deepest epidermal cells are anchored to the 
basement membrane by adhesion molecules (or glue); namely fibronectin. These immature cells are continually dividing and 
migrating toward the surface, to replace lost surface cells; e.g., after an injury. The same types of  regenerating epidermal cells 
are found in hair follicles and other skin appendages, which are anchored in the dermis. As the cells mature and migrate to 
the surface, they form keratin, which becomes an effective barrier to environmental hazards such as infection and excess 
water evaporation.
The stratum corneum is the “outermost layer” of  the epidermis consisting of  several flattened layers of  dead keratinocytes 
as well as keratin. This layer protects against entry of  bacteria and toxins. 
Replacement of  the epidermal layer by this regenerative process takes 2-3 weeks. However, regeneration depends on an 
optimal tissue-healing environment, which includes contact cues for cell replication and migration as well as chemical stimuli 
known as growth factors. These cues and stimuli at the wound surface are necessary to direct proper orientation and mitotic 
response of  the epidermal cells. Many of  the cues come from dermal elements, especially the matrix protein fibronectin, 
and matrix compounds such as hyaluronic acid.
Dermis – The dermis is divided into a thin, superficial layer known as the papillary dermis, containing the anchoring epider-
mal rete pegs and the thicker, deeper portion known as the reticular dermis. The papillary dermis is the most bioactive por-
tion of  the dermis. The primary cell type is the fibroblast, which produces the key structural extra cellular matrix proteins, 
collagen and elastin, as well as matrix or ground substance. In addition, these cells produce the key adhesion proteins used 
to attach epidermal cells to the basement membrane and are used for epidermal cell migration and replication. Fibronectin is 
a key fibroblast derived signal protein for orchestration of  healing. The ground substance or matrix is made up of  complex 
polysaccharide-protein complexes known as protein, glycosaminoglycans or the GAG component, as well as hyaluronic 
acid. The matrix is a semi-fluid that allows cell and connective tissue orientation, nutrient diffusion to the cells and also 
provides a scaffolding for cell migration. 
Basement Membrane – The interface between the layers of  the dermal-epidermal junction is the basement membrane, 
which anchors the epidermal cells from above and the dermis from below. 
Thickness – Average thickness of  the bilayer is 1-2 mm and is considerably thinner in infants and the elderly, especially the 
dermis that is underdeveloped in infants and atrophic in the elderly.
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coarse wrinkles [12-18]. Elastic fibers are another key protein in 
skin and reside in the papillary and reticular dermis. They provide 
elasticity and recoil capacity to skin. Certain diseases of  elastic 
fibers, such as Marfan’s syndrome (fibrillin-1 mutation) and Wil-
liams syndrome (elastin mutations), are characterized by loss of  
elasticity, much like that seen in aged skin. Clearly, loss and dam-
age of  elastic fibers are contributory to the clinical and molecular 
changes seen in aged skin, but, for practical reasons, the majority 
of  the research work being carried out is focused on collagen [12]. 
Collagen fibers provide “scaffolding” for fibroblasts; this scaf-
folding is critical for the maintenance of  the collagen network 
because it allows the fibroblasts to exist in a “stretched” configu-
ration, as a typical of  young, healthy, non-sun-damaged skin [15, 
16]. The fibroblasts appear elongated, with abundant endoplas-
mic reticulum indicative of  the active collagen protein-producing 
machinery. Collagen fibrils are intimately associated with these 
elongated fibroblasts and are seen in close proximity to them. In 
contrast, the fibroblasts in old and sun-damaged skin exist in a 
“collapsed” configuration, and the cells appear much smaller than 
the stretched fibroblasts [12, 15, 16]. There is minimal endoplas-
mic reticulum in these fibroblasts as seen by electron microgra-
phy, indicating that the collagen producing machinery is minimally 
productive. In old, sun-damaged skin, collagen fibrils are not seen 
in close proximity external to the fibroblasts and are fragmented. 
Therefore, it is important that the relationship between the fibro-
blasts and the collagen matrix is an interdependent one, with the 
fibroblasts serving as the structure or anchor for the collagen fib-
ers and the collagen fibers allowing the fibroblasts to exist in their 
“stretched” configuration [12, 15, 16]. 
The results demonstrate that age-related alterations in collagen 
and total protein metabolism of  skin fibroblasts in culture were 
similar to those reported previously for skin in vivo, suggesting 
that for studies of  these processes, fibroblasts in culture provide 
an appropriate model [19]. Age-related changes in collagen syn-
thesis in rat skin fibroblasts in vitro over 30 population doublings 
were determined based on the production of  hydroxy-[14C]pro-
Table 2. Skin Functions and Characteristics of  cell Elements of  the Skin.
Skin Functions 
Epidermis: Protection from desiccation 
Protection from bacterial entry 
Protection from toxins 
Fluid balance: avoiding excess evaporation loss 
Neurosensory 
Social interactive 
Epithelial Cells: These cells make up the majority of  the epidermis. Immature cells are programmed to divide, migrate, and 
mature to keratin-producing cells called keratinocytes. The signal to activate this process comes from messenger proteins 
called growth factors as well as through contact direction from key dermal adhesive proteins. 
Fibroblasts: These cells of  mesenchymal origin (embryonic connective tissues) are normally present in the dermis and 
produce normal dermal replacement components. After injury, these cells migrate into the wound and proliferate in order 
to produce increased quantities of  these dermal proteins and matrix. 
Fibroblast Products:
 • Collagen (Type I predominant in skin) 
 • Matrix proteins 
 • Proteoglycans, glycosaminoglycans, hyaluronic acid, other matrix components 
 • Growth factors and other growth stimulants 
Endothelial Cells: These cells make up the lining of  micro and macro vessels and also make up the lining of  new capillaries 
produced after injuries. These cells are attracted into the wounds by local signals. 
Macrophages: These cells of  mesenchymal origin (embryonic connective tissues) are normally present in tissues but in-
crease in number after injury, attracted by chemical messages released by the activation of  inflammation. These long-lived 
cells release the protein chemical messages, growth factors, and growth stimulants which orchestrate healing in an organized 
fashion. 
Platelets: These factor-rich particles release a host of  growth factors and adherence proteins during the initial post-burn 
period. 
Neutrophils: These short-lived cells have been an immune function and are the first cells migrating to the wound service. 
Their role is to control bacteria or other toxic elements from surface penetration. Excessive inflammation, as occurs with 
surface dead tissue or ongoing stimulation of  neutrophils sequestration, will impede healing. Surface exudate is rich in dean 
and dying neutrophils and in toxic protease activity.
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line. Degradation of  newly synthesized collagen was based on the 
appearance of  free hydroxy-[14C]proline in the culture system 
[19]. Total protein synthesis rates were based on the incorporation 
of  [14C]proline into proteins. In vitro rates of  collagen synthesis 
decreased 5-fold over 30 population doublings (P < 0.05). Deg-
radation of  newly synthesized collagen increased from 33.0 +/- 
0.8% (n = 4, SEM) to 45.2 +/- 1.1% (n = 4; P < 0.05) over the 
same period, with a maximum after 25 population doublings of  
55.8 +/- 1.1% (n = 4). Total protein synthesis rates decreased by 
one-half  over 30 population doublings (P < 0.05). The results 
indicated that collagen production in rat decreased as cells aged in 
vitro and that this was due to both changes in synthesis and degra-
dation. Senescent and ultraviolet-damaged fibroblasts also secrete 
enzymes that degrade the basement membrane, the dense matrix 
onto which the epithelial cells are organized. This may contrib-
ute to the age-dependent thinning of  the epidermis and the loss 
of  rete ridges, as the basement membrane is critically important 
for the proper organization and function of  epithelial cells [19]. 
Among the factors involved, the accumulation of  advanced gly-
cation end-products (AGEs) might well play an important role. 
Several of  such AGE-products showed a significant inhibition of  
collagen deposition. On the contrary, retinol, ascorbic acid as 
well as the rhamnose-rich oligo-and polysaccharides (RROPs) did 
produce a significant upregulation collagen deposition. Polysac-
charide preparations, rich in rhamnose and fucose (the EROB-
mixture) could protect against the AGEs-induced inhibition of  
collagen accumulation [20].
Extrinsic aging is associated with episodic photodamage, which 
culminates in permanent photoaging. Minimal erythema dose re-
fers to the amount of  UV radiation that causes barely perceptible 
skin reddening. A mere 0.01 minimal erythema dose leads to sta-
tistically significant injury that will induce the molecular sequence 
of  events resulting in collagen deficiency, collagenase excess, and 
micro- and macro-scarring leading to solar scars. These additive 
solar scars are associated with the clinical presentation of  wrinkles 
[12]. Both UVB and UVA radiation lead to an increase in reactive 
oxygen species (ROS). Specifically, exposure to two minimal ery-
thema doses leads to the production of  H2O2, which gives rise to 
other oxygen free radicals within minutes. ROS play an important 
role in direct cellular damage (cell walls, lipid membranes, mito-
chondria, and DNA) as well as in molecular signaling. Through 
ROS signaling, transforming growth factor-, a cytokine that 
promotes collagen production, is blocked, and the formation of  
new collagen is reduced. Also mediated through ROS signaling is 
the epidermal growth factor receptor pathway, which signals ac-
tivator protein-1, a transcription factor responsible for upregulat-
ing collagenase, a matrix metalloproteinase that is important in 
collagen breakdown. The upregulation of  collagenase leads to an 
increase in collagen fragmentation that in turn leads to a decrease 
in the mechanical tension of  the fibroblast [12]. Loss of  mechani-
cal tension leads to perpetuation of  the cycle in which collagenase 
concentration is increased, leading to further collagen fragmenta-
tion and, ultimately, permanent collagen loss clinically manifested 
as permanent photoaging. Each UV insult results in solar scars, 
which manifest as a wrinkle [21, 22]. Long-term exposure to ul-
traviolet irradiation from sunlight causes premature skin aging 
(photoaging), characterized in part by wrinkles, altered pigmenta-
tion, and loss of  skin tone. Multiple exposures to ultraviolet irra-
diation lead to sustained elevations of  matrix metalloproteinases 
that degrade skin collagen and may contribute to photoaging [22]. 
Photoaged skin displays prominent alterations in the collagenous 
extracellular matrix of  connective tissue. Molecular mechanisms 
by which ultraviolet light causes photoaging involve activation of  
growth factor and cytokine receptors in keratinocytes and dermal 
cells. They lead to downstream signal transduction through activa-
tion of  mitogen-activated protein kinase (extracellular signal-reg-
ulated kinase, c-jun N-terminal protein kinase, and p38) pathways. 
These signaling pathways converge in the nucleus of  cells to form 
an activated complex of  transcription factor activator protein 1 
(cFos/cJun), which induces matrix metalloproteinases that de-
grade skin connective tissue. In addition to cell surface receptor 
activation, generation of  ROS by ultraviolet radiation is believed 
to be critical in triggering mitogen-activated protein kinase path-
ways. Kang et al., [21] investigated the ability of  (i) ultraviolet ir-
radiation to generate ROS in human skin in vivo; and (ii) genistein, 
which possesses both tyrosine kinase inhibitory and antioxidant 
activities, and n-acetyl cysteine, which can be converted into the 
endogenous antioxidant glutathione, to impair responses to ul-
traviolet light that eventuate in photoaging in human skin in vivo. 
Ultraviolet irradiation caused a rapid and significant increase in 
hydrogen peroxide levels in human skin in vivo. Pretreatment of  
human skin with genistein inhibited ultraviolet-induced epidermal 
growth factor receptor tyrosine kinase activity, whereas n-acetyl 
cysteine did not. Genistein inhibited ultraviolet induction of  both 
extracellular signal-regulated kinase and cJun N-terminal protein 
kinase activities. n-Acetyl cysteine inhibited extracellular signal-
regulated kinase but not cJun N-terminal protein kinase activa-
tion. Both genistein and n-acetyl cysteine prevented ultraviolet 
induction of  cJun protein. Consistent with this, genistein and 
n-acetyl cysteine blocked ultraviolet induction of  cJun-driven en-
zyme, collagenase. Neither genistein nor n-acetyl cysteine acted as 
sunscreens as they had no effect on ultraviolet-induced erythema. 
These data indicate that compounds similar to genistein and n-
acetyl cysteine, which possess tyrosine kinase inhibitory and/
or antioxidant activities, may prevent photoaging [21]. N-acetyl-
cysteine has been used as the active ingredient in the formulation 
of  non-hydrolized carnosine proposed in this study (Figure 7).
The sequence of  events in intrinsic aging is similar but with a 
few notable exceptions. The damage in natural aging is continu-
ous rather than episodic and is caused by the passage of  time 
rather than by UV damage. The increase in ROS signaling leads 
to a decrease in collagen formation mediated by transforming 
growth factor-, as in extrinsic aging. The increase in collagenase 
level, however, is mediated through the JNK pathway rather than 
through the epidermal growth factor receptor pathway. The above 
discussion is focused on collagen in aging skin because most of  
the ongoing research is focused on this vital skin protein. There 
have, however, been findings to suggest that there is a difference 
between photoprotected and photodamaged skin with regard to 
extracellular protein matrix. The extracellular matrix is important 
because of  its water-binding capacity. Four glycosaminoglycans 
were identified in skin samples: hyaluronic acid (HA), heparan 
sulfate, dermatan sulfate and chondroitin sulfate [12, 23]. In a 
study of  photodamaged facial skin as compared with photopro-
tected postauricular skin used as a control, photoexposed skin 
was observed to have a significant increase in the content of  HA 
and DS as compared with photoprotected skin. The increase in 
HA was associated with an increase in the amount of  fragmented 
HA, which is abnormal and does not interact in the usual manner 
with water [12, 24].
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Age-dependent changes in fibroblast physiology (senescent phe-
notype of  fibroblasts) may also contribute to the increased inci-
dence of  cancer that is a hallmark of  mammalian aging. Several 
lines of  evidence suggest mutations and loss of  normal tissue 
structure synergize to generate the exponential rise in cancer that 
occurs with age [25]. Tissue structure and integrity are critically 
dependent on an intact stromal and basement membrane, both of  
which are disrupted by senescent or damaged fibroblasts. In addi-
tion, senescent fibroblasts secrete epithelial growth factors, which 
can stimulate the growth of  epithelial cells that have acquired po-
tentially oncogenic mutations.
In summary of  this section of  the article, fibroblasts undergo 
physiological changes with age. These changes are induced by 
environmental and intrinsic factors, and disrupt the integrity of  
the stroma and basement membrane. Both these structures are 
critical in order for epithelial cells, and hence tissues, to carry out 
their normal functions. These structures are also important for 
suppressing the progression of  cancer.
Variants, Causes and Factors of  Skin Aging
Advances in research have yielded a tremendous amount of  in-
formation on the molecular pathways involved in both intrinsic 
aging (natural) and extrinsic aging (photoaging) [9]. Both genetic 
(intrinsic) and environmental (extrinsic) factors contribute to the 
phenotypic changes in cutaneous aging. Apart from them, so 
called stochastic aging connotes cell damage caused by metabolic 
processes, free radicals and cosmic irradiation. Extrinsically aged 
skin shows signs of  photodamage which include appearance of  
wrinkles (Figure 2a), pigmented lesions (Figure 2b), actinic kera-
toses and patchy hypopigmentations. Extrinsic aging is caused by 
environmental factors such as sun exposure, air pollution, smok-
ing, alcohol abuse, and poor nutrition.
Intrinsic aging reflects the genetic background and depends on 
time. Various expressions of  intrinsic aging include smooth, thin-
ning skin with exaggerated expression lines. It is inevitable and 
time dependent.
Extrinsically aged skin is characterized by photo damage as wrin-
kles, pigmented lesions, patchy hypopigmentations, and actinic 
keratoses. Therapeutic modalities imply photoprotection with 
sunscreens that prevent sunburns and block ultraviolet irradia-
tion.
Other modalities include use of  retinoids which regulate gene 
transcription with subsequent cellular differentiation and prolif-
eration. The topical and peroral administration of  network anti-
oxidants, such as vitamin E and C, coenzyme Q10, alpha-lipoic 
acid and glutathione, enhance anti-aging effect. The other antioxi-
dants such as green tea, dehydroepiandrosterone, melatonin, se-
lenium and resveratrol, have also antiaging and anti-inflammatory 
effects. Topical bleaching agents such as hydroquinone, kojic acid 
and azelaic acid can reduce signs of  aging. Studies confirm the 
efficacy of  these topical agents in combination with superficial 
and/or medium depth or deep peeling agents for photodamaged 
skin treatment. Indications for type of  chemical peels according 
to various clinical diagnosis are done, as well as advantages and 
disadvantages of  different types of  chemical peels [3, 26].
However, only recently have the underlying molecular mecha-
nisms involved in these changes been elucidated. DNA damage 
to both genomic and mitochondrial DNA and subsequent DNA 
repair contribute greatly to age-associated skin changes and car-
cinogenesis. Better understanding of  these intricate, interwoven 
mechanisms involved in DNA damage and repair might help to 
develop new strategies in preventing and treating changes of  in-
trinsic skin aging and photoaging, improving skin appearance [27]. 
The dramatic increase in the aging population and the psycho-
social impact of  skin aging has created a demand for effective 
interventions. The advances that have been made in the past 25 
Figure 2. A. Skin Wrinkles; B. Pigmented Skin Lesions.
(A) (B)
Although people may have a genetic predisposition to severe wrinkling, it is known that sun exposure promotes and exacerbates wrin-
kling of  the skin. Smoking may also negatively affect the skin. As a person ages, skin cells divide more slowly, and the inner skin, or 
dermis, starts to thin. Fat cells beneath the dermis begin to atrophy, and the underlying network of  elastin and collagen fibres, which 
provides scaffolding for the surface layers, loosens and unravels. Skin loses its elasticity; when pressed, it no longer springs back to its 
initial position but instead sags and forms furrows. The skin's ability to retain moisture diminishes; the sweat and oil-secreting glands 
atrophy, depriving the skin of  their protective water lipid emulsions. As a consequence, the skin becomes dry and scaly. In addition, the 
ability of  the skin to repair itself  diminishes with age, so wounds are slower to heal.
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years in our understanding of  the clinical, biochemical, and mo-
lecular changes associated with aging have led to the development 
of  many different approaches to reduce, postpone, and in some 
cases, repair the untoward effects of  intrinsic programmed aging 
and extrinsic environmental injury [4, 27]. The pathogenesis of  
skin degeneration includes natural and aggravating factors [1, 13-
15]. These factors are heredity which is internal and hard to con-
trol and environmental which is external [1, 3, 4-7, 26]. Instances 
of  the latter are cigarette smoke, water and air pollutions, and 
sunlight. Sunlight has the most influence on skin degeneration 
[3, 27]. Chronic sun exposure causes photoaging of  human skin, 
a process that is characterized by clinical, histological and bio-
chemical changes which differ from alterations in chronologically 
aged but sun-protected skin. Within recent years, substantial pro-
gress has been made in unraveling the underlying mechanisms of  
photoaging. Induction of  matrix metalloproteinases as a conse-
quence of  activator protein (AP)-1 and nuclear factor (NF)-KB 
activation as well as mutations of  mitochondrial DNA have been 
identified recently. This has increased our understanding of  pho-
toaging significantly and has led to new prophylactic and thera-
peutic strategies aimed at the prevention and repair of  the detri-
mental effects of  chronic sun exposure on the skin [8].
Reactive Oxygen Species and Aging
Severe oxidative stress progressively leads to cell dysfunction and 
ultimately cell death. Oxidative stress is defined as an imbalance 
between pro-oxidants and/or free radicals on the one hand, and 
anti-oxidizing systems on the other. The oxygen required for liv-
ing may indirectly be responsible for negative effects; these del-
eterious effects are due to the production of  free radicals, which 
are toxic for the cells (superoxide anion radicals, hydroxyl radicals, 
peroxyl radicals, hydrogen peroxide, hydroperoxides and perox-
initrite anions). Free radical attacks are responsible for cell dam-
age and the targeted cells are represented by the cell membranes, 
which are particularly rich in unsaturated fatty acids, sensitive to 
oxidation reactions; DNA is also the target of  severe attacks by 
these ROS [29, 30].
The Defence Systems: These are represented by the enzymes 
and free radical captors. The latter are readily oxidizable compos-
ites. The free radical captor or neutralization systems of  these 
ROS use a collection of  mechanisms, vitamins (E and C), enzymes 
[superoxide dismutase (SOD), glutathione peroxidase (GPx) and 
others], and glutathion reductase (GSH), capable of  neutralizing 
peroxinitrite. The efficacy of  this system is dependent on the ge-
nome for the enzymatic defence systems, and on nutrition for the 
vitamins. Some strategies aimed at reducing oxidative stress-re-
lated alterations have been performed in animals. However, only 
a few can be used and are efficient in humans, such as avoidance 
of  unfavourable environmental conditions (radiation, dietary car-
cinogens, smoking etc.) and antioxidant dietary supplementation.
Dietary Supplementation: Epidemiological data suggest that 
antioxidants may have a beneficial effect on many age-related dis-
eases: atherosclerosis, cancer, skin appearance, some neurodegen-
erative and ocular diseases. However, the widespread use of  sup-
plements is hampered by several factors: the lack of  prospective 
and controlled studies; insufficient knowledge on the pro-oxidant, 
oxidant and antioxidant properties of  the various supplements; 
growing evidence that free radicals are not only by-products, but 
also play an important role in cell signal transduction, apoptosis 
and infection control [28, 29].
Biomarkers of  Intrinsic Skin Aging: Telomeres, 
Hormone Activity and Other Intrinsic Factors 
that Affect Manifestations of  Skin Aging
Intrinsic aging, also known as the natural aging process, is a con-
tinuous process that normally begins in our mid-20s. Within the 
skin, collagen production slows, and elastin, the substance that 
enables skin to snap back into place, has a bit less spring. Dead 
skin cells do not shed as quickly and turnover of  new skin cells 
may decrease slightly. While these changes usually begin in our 
20s, the signs of  intrinsic aging are typically not visible for dec-
ades. The signs of  intrinsic aging are presented in Table 3. Genes 
control how quickly the normal aging process unfolds. Some no-
tice those first gray hairs in their 20s; others do not see graying 
until their 40s. People with Werner’s syndrome, a rare inherited 
condition that rapidly accelerates the normal aging process, usu-
ally appear elderly in their 30s. Their hair can gray and thin con-
siderably in their teens. Cataracts may appear in their 20s. The 
average life expectancy for people with Werner’s syndrome is 46 
years of  age.
Intrinsic aging depends on time. The changes occur partially as 
the result of  cumulative endogenous damage due to the continu-
ous formation of  ROS, which are generated by oxidative cellular 
metabolism. Despite a strong antioxidant defense system, dam-
age generated by ROS affects cellular constituents such as mem-
branes, enzymes, and DNA [26, 30, 31]. It has a genetic back-
ground, but is also due to decreased sex hormone levels.
Table 3. Clinical Biomarkers of  Intrinsic Aging.
 • Fine wrinkles
 • Thin and transparent skin
 • Loss of  underlying fat, leading to hollowed cheeks and eye sockets as well as noticeable loss of  firmness on the 
 hands and neck
 • Bones shrink away from the skin due to bone loss, which causes sagging Skin
 • Dry skin that may itch
 • Inability to sweat sufficiently to cool the skin
 • Graying hair that eventually turns white 
 • Hair loss
 • Unwanted hair
 • Nail plate thins, the half  moons disappear, and ridges develops
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Telomeres and Cell Senescence
Telomeres are located at the end of  the chromosomes and consist 
of  an evolutionary conserved repetitive nucleotide sequence rang-
ing in length from a few hundred base pairs in yeast till several kilo 
base pairs in vertebrates. The telomere, a terminal portion of  the 
eukaryotic chromosome, plays an important role. With each cell 
division, the length of  the human telomere shortens. In all mam-
mals telomeres are short sequences of  bases and are arranged 
in the same mode (TTAGGG) and so the enzyme telomerase is 
responsible for its maintenance (Figure 3) [32-34]. Telomere pro-
tects the end of  the chromosome from fusion or deletion and 
maintains the stability of  the chromosome and is synthesized by 
telomerase, a ribonucleoprotein. Telomere reduction is observed 
with cell senescence and immortalization, both in vivo and in vitro. 
Thus, telomere is considered to be a "clock" which measures the 
life span of  cells, and its length is altered by cellular senescence 
and immortalization [32]. Telomeres have been postulated as a 
universal biological clock that shortens in parallel with aging in 
cells [33, 34]. Even in fibroblasts of  quiescent skin more than 
30% of  the telomere length is shortened during adulthood [33]. 
Telomeres associate with shelter in proteins and form a complex 
protecting the chromosomal deoxyribonucleic acid (DNA) from 
recognition by the DNA damage repair system. Due to the "end-
replication problem" telomeres shorten with each mitotic cycle 
resulting in cumulative telomere attrition during aging. When tel-
omeres reach a critical length the cell will not further undergo 
cell divisions and become senescent or otherwise dysfunctional. 
Telomere shortening has not only been linked to aging but also 
to several age associated diseases, including tumorigenesis, coro-
nary artery disease, and heart failure [34]. In the current review, 
we discuss the role of  telomere biology in relation to skin aging, 
senescence phenotype of  the dermal fibroblasts and skin aging 
associated diseases.
Telomerase and telomeres have been shown to be involved in the 
control of  cell proliferation, the regulation of  cell senescence and 
the unlimited proliferation capacity of  malignant cells (reviewed 
in ref. [35]). Human telomeres function to protect chromosomes 
from degradation, fusion and recombination. Since the termini 
of  linear molecules are replicated only in the 5'-3' direction by 
conventional DNA polymerases and require an RNA primer to 
initiate DNA synthesis, the removal of  the RNA primer results 
Figure 3. A. Chromosomes (stained blue) end in protective caps called telomeres (stained yellow), which are shorter in per-
sons suffering chronic stress. B. DNA damage with reactive oxygen species. C. Telomere length is maintained in species-
specific equilibrium primarily through a competition between telomerase-mediated elongation and the loss of  terminal 
DNA through the end-replication problem. Telomerase is a ribonucleoprotein (a ribonucleic acid-protein complex). It is an 
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in DNA loss with each cell division. To date, telomere shorten-
ing has been observed in most dividing somatic cells, eventually 
leading to cell senescence when critically short telomeres are 
reached. Borderline telomerase activity has been detected in hu-
man primitive hematopoietic cells and in stimulated lymphocytes 
which increased with cytokine induced ex vivo expansion. How-
ever, in most other normal somatic cells, telomerase has not been 
detected, and consequently telomere shortening can be anticipat-
ed after a limited number of  population doublings. In contrast, 
spontaneously immortalized tumor cell lines and the majority 
of  malignant tumors demonstrate high telomerase activity, sta-
ble telomere length and unlimited proliferative potential. Mecha-
nisms for telomerase and telomere length regulation are under 
extensive investigation. These have included the cloning of  the 
RNA component and telomerase associated proteins, antisense 
experiments that have demonstrated progressive telomere length 
shortening in the absence of  telomerase, and the identification of  
telomere binding proteins which may regulate telomerase by cre-
ating a negative feedback signal (reviewed in ref. [35]). Telomeres 
play a central role in cell fate and aging by adjusting the cellular 
response to stress and growth stimulation on the basis of  previ-
ous cell divisions and DNA damage. At least a few hundred nu-
cleotides of  telomere repeats must "cap" each chromosome end 
to avoid activation of  DNA repair pathways. Repair of  critically 
short or "uncapped" telomeres by telomerase or recombination is 
limited in most somatic cells and apoptosis or cellular senescence 
is triggered when too many "uncapped" telomeres accumulate. 
The chance of  the latter increases as the average telomere length 
decreases. The average telomere length is set and maintained in 
cells of  the germline which typically express high levels of  telom-
erase. In somatic cells, telomere length is very heterogeneous but 
typically declines with age, posing a barrier to tumor growth but 
also contributing to loss of  cells with age [36].
Initially, when human fibroblasts from different donors are grown 
in vitro, only a small fraction of  the variation in their finite replica-
tive capacity is explained by the chronological age of  the donor 
[33]. Because telomeres, the terminal guanine-rich sequences of  
chromosomes, shorten throughout the life span of  cultured cells, 
Allsopp et al., [33] wished to determine whether variation in initial 
telomere length would account for the unexplained variation in 
replicative capacity. Analysis of  cells from 31 donors (aged 0-93 
yr) indicated relatively weak correlations between proliferative 
ability and donor age (m = -0.2 doubling per yr; r = -0.42; P = 
0.02) and between telomeric DNA and donor age (m = -15 base 
pairs per yr; r = -0.43; P = 0.02). However, there was a striking 
correlation, valid over the entire age range of  the donors, between 
replicative capacity and initial telomere length (m = 10 doublings 
per kilobase pair; r = 0.76; P = 0.004), indicating that cell strains 
with shorter telomeres underwent significantly fewer doublings 
than those with longer telomeres. These observations suggest that 
telomere length is a biomarker of  somatic cell aging in humans 
and are consistent with a causal role for telomere loss in this pro-
cess (Figure 4) [33]. Moreover, variation in the initial length of  
terminal restriction fragments (TRF) accounts for much of  the 
variation in replicative capacity of  fibroblast cultures from dif-
ferent donors. Since replicative capacity also varies significantly 
between clones in a mass culture of  fibroblasts from a single do-
nor, Allsopp et al., [37] wished to further test the hypothesis that 
the shortening of  telomeres to a critical or threshold length acts 
as a signal for cell senescence. Thus, Allsopp et al., [37]] meas-
ured TRF length and total telomeric signal intensity for 35 clonal 
fibroblast populations at early passage and at senescence. Replica-
tive capacity was found to be directly proportional to mean TRF 
length (m = 7.2 population doublings/kbp, r = 0.65, P = 0.0004) 
and total signal intensity (m = 25.0 population doublings/unit, r 
Figure 4. Consequences of  human skin fibroblasts telomerization. a. Growth curves of  the cells after introduction of  hTERT gene. 1608 – 
original adult skin fibroblast strain. They stop proliferation after 68 PD. 1608tel7, 1608tel2 and 1608tel1.2 – different clones. b. high density 
monolayer of  telomerized cells. c. Increasing of  telomere length after telomerization (Southern blot). 1 – original cells, 2 – 7 different 
clones of  telomerized cells, at left – DNA size markers (kb). d. Normal karyotype of  telomerized cells. e. increasing of  saturated density 
of  proliferation after telomerization. Old cells (strain 1608 57PDL (population doubling level)) have very low density of  monolayer. Young 
cells (1608 21PDL) form monolayer of  increased density and telomerized cells (1608telmix and 1608telmixclone) form very high density 
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= 0.63, P < 0.003) at early passage. More importantly, the variabil-
ity in both mean TRF length and signal intensity (F = 2.0 and 2.9; 
P = 0.02 and 0.03, respectively) at senescence was markedly less 
than that at early passage. Although initial telomere length cannot 
account for all of  the interclonal variability in replicative capac-
ity, the observations support the existence of  a critical telomere 
length in senescing cells and a causal role of  telomere shortening 
in cell senescence [37]. Thus, it has been documented that the loss 
of  telomere repeats was causally linked to in vitro replicative se-
nescence of  human diploid fibroblasts (HDFs). In order to study 
the mechanism(s) by which telomere shortening signals cell senes-
cence, Martens et al. analyzed the telomere length at specific chro-
mosome ends at cumulative population doublings in polyclonal 
and clonal HDFs by quantitative fluorescence in situ hybridiza-
tion [38]. The rate of  telomere shortening at individual telomeres 
varied between 50 and 150 bp per population doubling and short 
telomeres with an estimated 1-2 kb of  telomere repeats accumu-
lated prior to senescence. The average telomere length in spe-
cific chromosome ends was remarkably similar between clones. 
However, some exceptions with individual telomeres measuring 
0.5-1 kb were observed. In the fibroblast clones, the onset of  
replicative senescence was significantly correlated with the mean 
telomere fluorescence but, strikingly, not with chromosomes with 
the shortest telomere length. The accumulation of  short telomer-
es in late passages of  cultured HDFs is compatible with selection 
of  cells on the basis of  telomere length and limited recombina-
tion between telomeres prior to senescence [38].
It seems that telomeres are responsible for longevity. Recent 
studies indicate that telomere length, which can be affected by 
various lifestyle factors, can affect the pace of  aging and onset 
of  age-associated diseases (reviewed in ref. [39]). Telomere length 
shortens with age. Progressive shortening of  telomeres leads to 
senescence, apoptosis, or oncogenic transformation of  somatic 
cells, affecting the health and lifespan of  an individual. Shorter 
telomeres have been associated with increased incidence of  dis-
eases and poor survival. The rate of  telomere shortening can be 
either increased or decreased by specific lifestyle factors. Better 
choice of  diet and activities has great potential to reduce the rate 
of  telomere shortening or at least prevent excessive telomere at-
trition, leading to delayed onset of  age-associated diseases and 
increased lifespan (reviewed in ref. [38]). Our own work high-
lights the role of  telomeres in dermal fibroblasts in skin aging 
and describes the lifestyle therapeutic nutritional factors including 
non-hydrolized imidazole containing dipeptide based compounds 
(non-hydrolized carnosine, carcinine) which may affect telomeres, 
human health, and skin aging [40-44].
The progressive erosion of  the telomere sequence (50–100 bp per 
mitosis) through successive cycles of  replication eventually pre-
cludes protection of  the ends of  the chromosomes, thus prevent-
ing end-to-end fusions, which is incompatible with normal cell 
function. The majority of  cells have the capacity for about 60 to 
70 postnatal doublings during their lifecycles, and thereafter they 
reach senescence, remaining viable but incapable of  proliferation. 
This event facilitates end-to-end chromosomal fusions resulting 
in karyotype disarray with subsequent apoptosis, thus serving as 
the “biological clock” [34, 45]. 
Hormone and cytokine signaling activities and skin aging
Skin aging is affected also by growth factor modifications and 
hormone activity that declines with age. The best-known decline 
is that of  sex steroids such estrogen, testosterone, dehydroepian-
drosterone (DHEA), and its sulfate ester (DHEAS). The effect of  
this decrease on the skin has been poorly documented, although 
more data are available for estrogen than for other hormones [46-
48]. Other hormones such as melatonin, insulin, cortisol, thyrox-
ine, and growth hormone decline too.
A progressive decrease in androgen production is common in 
aging men. The physiological causes for this phenomenon seem 
to be multifactorial [46]. The magnitude of  the decline in tes-
tosterone with age and the prevalence of  older men with low 
testosterone levels have not been well established. The extent to 
which an age-dependent decline in androgen levels leads to health 
problems that might affect or alter the quality of  life remains 
under debate. In men older than middle age, total testosterone 
levels may be misleading because of  an increase in sex hormone-
binding globulin levels. The mechanism of  the age-associated de-
crease of  the endocrine testicular function is also essentially due 
to primary testicular failure, but important changes occur at the 
hypothalamo-pituitary level. The most prominent endocrinologi-
cal alterations with aging are related to the sex steroids, but oth-
ers, such as growth hormone, melatonin cortisol, and thyroxine, 
are also affected. The clinical picture of  andropause syndrome 
is characterized by diminished sexual desire and erectile capac-
ity, decrease in intellectual activity, fatigue, depression, decrease in 
lean body mass, skin alterations, decrease in body hair, decrease in 
bone mineral density that results in osteoporosis, and increase in 
visceral fat and obesity. Clinical response is a better guide to dose 
requirements, regardless of  serum testosterone levels [46].
Aging is associated with a decline in immunity described as im-
munosenescence. This is paralleled by a decline in the production 
of  several hormones, as typically illustrated by the menopausal 
loss of  ovarian oestrogen production. However, other hormonal 
changes that occur with aging and that potentially impact on im-
mune function include the release of  the pineal gland hormone 
melatonin and pituitary growth hormone, adrenal production of  
dehydroepiandrosterone and tissue-specific availability of  active 
vitamin D [48]. At the same time, induced levels of  certain signal-
ing molecules such as cytokines and chemokines decline as well, 
leading to the deterioration of  several skin functions [49]. Also, 
the levels of  their receptors decline as well [50]. An elevation of  
monocyte chemoattractant protein (MCP-1) levels was observed 
in wounds of  aged mice. RNase protection studies, however, re-
vealed that the production of  most chemokines, including MIP-2, 
MIP-1alpha, MIP-1beta, and eotaxin, tended to decline with age 
[49]. Because optimal wound healing requires both appropriate 
macrophage infiltration and phagocytic activity, phagocytosis was 
examined. Compared to young mice, wound macrophages from 
aged mice exhibited a 37%-43% reduction in phagocytic capacity. 
Taken together, the data demonstrate age-related shifts in both 
macrophage and T cell infiltration into wounds, alterations in 
chemokine content, and a concurrent decline in wound mac-
rophage phagocytic function. These alterations may contribute 
to the delayed repair response of  aging [49]. According to the 
somatomedin model, growth hormone (GH)-dependent hepatic 
synthesis is responsible for maintaining circulating insulin-like 
growth factor (IGF)-I levels. On the other hand, the local auto-
crine/paracrine IGF-I expression in peripheral tissue is generally 
GH-independent and reflects the effects of  various and tissue-
specific trophic hormones. Circulating IGF-I levels undergo im-
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portant age-related variations increasing at puberty and decreas-
ing, thereafter, to low levels in the elderly. Low IGF-I levels in 
the elderly mainly reflect impaired somatotroph secretion but the 
decline in gonadal sex steroid levels, some protein and micronu-
trients malnutrition as well as age-dependent variations in IGF-
binding proteins may also play a role in the age-related decrease 
in IGF-I activity [50].
At the same time, some signaling molecules increase with age. 
One of  these is a cytokine called transforming growth factor 
-beta1, which induces fibroblast senescence. Cellular senescence 
is a result of  molecular alterations in the cellular milieu as well as 
in DNA and proteins within the cell. All of  these changes gradu-
ally lead to aberrant cellular response to environmental factors, 
which can decrease viability and lead to cell death [51]. 
Stress-induced premature senescence of  human diploid fi-
broblasts
Replicative senescence of  HDFs or melanocytes is caused by 
the exhaustion of  their proliferative potential. Stress-induced 
premature senescence (SIPS) occurs after many different suble-
thal stresses including H2O2 (Figure 5), hyperoxia, or tert-butyl 
hydroperoxide. Cells in replicative senescence share common 
features with cells in SIPS: morphology, senescence-associated 
beta-galactosidase activity, cell cycle regulation, gene expression 
and telomere shortening. Telomere shortening is attributed to the 
accumulation of  DNA single-strand breaks induced by oxidative 
damage. SIPS could be a mechanism of  accumulation of  senes-
cent-like cells in vivo. Melanocytes exposed to sublethal doses of  
UVB undergo SIPS. Melanocytes from dark- and light- skinned 
populations display differences in their cell cycle regulation. De-
layed SIPS occurs in melanocytes from light-skinned populations 
since a reduced association of  p16(Ink-4a) with CDK4 and re-
duced phosphorylation of  the retinoblastoma protein are ob-
served. The role of  reactive oxygen species in melanocyte SIPS is 
unclear. Both replicative senescence and SIPS are dependent on 
two major pathways. One is triggered by DNA damage, telomere 
damage and/or shortening and involves the activation of  the p53 
and p21(waf-1) proteins. The second pathway results in the accu-
mulation of  p16(Ink-4a) with the MAP kinase signalling pathway 
as possible intermediate [52].
Normal HDFs exposed to various types of  noncytotoxic oxida-
tive stress display a senescent-like phenotype coined SIPS [52]. 
Such stressful conditions include exposure to hydrogen peroxide 
[53, 54], tert-butyl hydroperoxide (t-BHP) [55], hyperoxia [56], 
UV light [57], and radioactivity [58]. Many biomarkers of  repli-
cative senescence appear in SIPS: typical cell morphology [55], 
irreversible growth arrest, lack of  response to mitogenic stimuli 
[54], sharp decrease of  the DNA synthesis, and an increase in 
cells positive for the senescent-associated β-galactosidase activity 
(SA β-gal) [59]. 
SIPS is induced 3 days after exposure of  HDFs to subcytotoxic 
oxidative stress with H2O2, with appearance of  several biomarkers 
of  replicative senescence [51]. In this work, Frippiat C et al., [51] 
show that transforming growth factor-beta1 (TGF-beta1) regu-
lates the induction of  several of  these biomarkers in SIPS: cellu-
lar morphology, senescence-associated beta-galactosidase activity, 
increase in the steady state level of  fibronectin, apolipoprotein 
J, osteonectin, and SM22 mRNA. Indeed, the neutralization of  
TGF-beta1 or its receptor (TGF-beta RII) using specific antibod-
ies decreases sharply the percentage of  cells positive for the se-
Figure 5. Protective effect of  carnosine on primary skin fibroblast colony formation under oxidative stress conditions. The 
primary culture of  human adult skin fibroblasts was monitored (strain 1608), N (ordinate), the number of  colonies. Ab-
scissa, colony size, (number of  cells). Hydrogen peroxide concentration is 100µM, carnosine concentration is 20mM. Total 
quantity of  cells per dish are: control 725±98 (SD), in the presence of  hydrogen peroxide (100µM) - 165±22 , and in the pres-
ence hydrogen peroxide (100µM) and carnosine (20mM) - 719±113. Each experimental point represents a result of  at least 6 
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nescent-associated beta-galactosidase activity and displaying a se-
nescent morphology. In the presence of  each of  these antibodies, 
the steady state level of  fibronectin, osteonectin, apolipoprotein 
J, and SM22 mRNA is no more increased at 72 h after stress [51]. 
Conditions to induce and parameters to evaluate sublethal oxida-
tive stress of  cultured human fibroblasts have been investigated in 
the attempt to identify markers for a more accurate quantification 
of  cell injury. Sublethal oxidative stress was obtained by treating 
fibroblasts with 0.5 mM H2O2 in Dulbecco's modified Eagle's 
medium (DMEM) plus 5% fetal calf  serum (FCS) for times not 
exceeding 60 min. Under these conditions cells remained viable 
throughout long-term incubation, showing no appreciable release 
of  cytosolic enzymes into the medium. On the contrary, expo-
sures of  fibroblasts to 0.5 mM H2O2 for times > 60 min induced a 
lethal cell injury which was fully expressed 2 days later by massive 
monolayer wasting and leakage of  cytosolic components. Early 
metabolic effects of  sublethal stress consisted of  a rapid and 
significant fall of  both ATP and NAD+ pools. Concomitantly, 
there was a moderate increase (about threefold) in both ADP-
ribosyl transferase activity and free [Ca2+]i, while the specific ac-
tivity of  glyceraldehyde-3-phosphate dehydrogenase was partially 
decreased upon treatment. Oxidative injury also caused delayed 
effects consisting of  a large depression of  both protein and DNA 
synthesis. However, while the former was partially restored within 
10 days of  incubation, the latter remained severely impaired, as 
encountered in a growth-arrested population. Microfilaments of  
H2O2-treated cells appeared to be morphologically altered due to 
partial fragmentation of  cytoskeleton actin which, however, was 
still maintained in the polymerized form as F-actin. Moreover, 
sublethally injured fibroblasts exhibited a reduced adhesiveness 
to plastic once they were detached and reseeded into new dishes. 
Relative adhesion efficiencies (number of  adherent cells at 16 h 
as a percentage of  seeded cells) were found to correlate inversely 
with times of  exposure to H2O2. This finding allowed the identi-
fication of  a biological parameter which showed itself  to be very 
sensitive to oxidative stress [53]. Human diploid fibroblast cells 
lose replicative potential after a certain number of  population 
doublings. Chen and Ames [54] used this experimental system to 
investigate the role of  oxidative damage in cellular aging. Treat-
ing cells with H2O2 at < 300 microM did not affect the viability 
of  the majority of  cells when judged by morphology, trypan blue 
exclusion, and protein synthesis. However, the treatment caused 
a dose-dependent inhibition of  DNA synthesis. After a 2-hr 
treatment with 200 microM H2O2, the cells failed to respond to 
a stimulus of  serum, platelet-derived growth factor, basic fibro-
blast growth factor, or epidermal growth factor by synthesizing 
DNA, and the loss of  response could not be recovered by 4 days. 
Subcultivation showed that, as in senescent cells, division of  the 
treated cells was inhibited. The life time cumulative growth curve 
showed that the loss of  replication due to H2O2 treatment was 
cumulative and irreversible. The H2O2 treatment decreased the 
number of  the population doublings in the rest of  the life span 
by 35.3 +/- 10.3%. Enzymatic assays indicated that, like the cells 
in their senescent state, the treated cells were less able to activate 
ornithine decarboxylase and thymidine kinase [54]. Mild oxidative 
stress as exerted by culture of  human WI-38 fibroblasts under 
40% oxygen partial pressure blocks proliferation irreversibly after 
one to three population doublings. Hyperoxically blocked cells are 
similar to senescent ones in terms of  general morphology and 
lipofuscin accumulation [56]. Moreover, they, like senescent fibro-
blasts, are blocked preferentially in G1 as evident from DNA con-
tent measurements by flow cytometry. Southern blotting of  Alu 
I and Hinf  I restricted genomic DNA shows an increase of  the 
rate of  telomere shortening from 90 bp per population doubling 
under normoxia to more than 500 bp per population doubling un-
der hyperoxia. In every case, proliferation is blocked if  a telomere 
cutoff  length of  about 4 kb is arrived at. The fact that telomere 
length correlates with the final inhibition of  proliferation under 
conditions of  varied oxidative stress, while the population dou-
bling level does not, suggests that telomere shortening provides 
the signal for cell cycle exit in senescence. In postmitotic cells, no 
further telomere shortening occurs. However, the sensitivity of  
terminal restriction fragments to S1 nuclease increases, indicating 
the accumulation of  single-strand breaks in telomeres of  nondi-
viding fibroblasts. This effect is found both under normoxic and 
hyperoxic culture, although it is more pronounced under condi-
tions of  higher oxidative stress [56].
Ionizing radiation both in low and high dose ranges exerts dif-
ferential effects on the cellular processes of  differentiation and 
proliferation in human skin fibroblasts [58]. Single irradiations of  
fibroblasts in the dose range of  1 to 8 Gy induced terminal dif-
ferentiation into postmitotic fibrocytes at high percentage level. 
Irradiation of  long-term cultures of  fibroblasts with repeated 
doses of  0.2, 0.6 and 1.0 Gy revealed that only in cultures, which 
were irradiated repeatedly (x 10) with 0.6 and 1.0 Gy a marked 
reduction of  the proliferation capacity was apparent. Inhibition 
of  proliferation by repeated irradiations with cumulative doses 
up to 10 Gy was not more pronounced as compared to single 
irradiations [58].
Dumont and Burton [60] tested the long-term effects of  suble-
thal oxidative stresses on replicative senescence. WI-38 HDFs at 
early cumulative population doublings (CPDs) were exposed to 
five stresses with 30 microM I-BHP. After at least 2 d of  recovery, 
the cells developed biomarkers of  replicative senescence: loss of  
replicative potential, increase in senescence-associated beta-ga-
lactosidase activity, overexpression of  p21(Waf-1/SDI-1/Cip1), 
and inability to hyperphosphorylate pRb. The level of  mRNAs 
overexpressed in senescent WI-38 or IMR-90 HDFs increased 
after five stresses with 30 microM I-BHP or a single stress under 
450 microM H2O2. These corresponding genes include fibronec-
tin, osteonectin, alpha1(I)-procollagen, apolipoprotein J, SM22, 
SS9, and GTP-alpha binding protein. The common 4977 bp mi-
tochondrial DNA deletion was detected in WI-38 HDFs at late 
CPDs and at early CPDs after I-BHP stresses. In conclusion, sub-
lethal oxidative stresses lead HDFs to a state close to replicative 
senescence [59].
Clinical Manifestations of  Intrinsic Aging
Clinical manifestations of  aged skin are xerosis, laxity, wrinkles, 
slackness, and the occurrence of  benign neoplasms such as seb-
orrheic keratoses and cherry angiomas. There are histological fea-
tures that accompany these changes. In the epidermis, there is 
no alteration in the stratum corneum and epidermal thickness, 
keratinocyte shape, and their adhesion, but a decreased number 
of  melanocytes and Langerhans cells is evident [31]. The most 
obvious changes are at the epidermal-dermal junction: flattening 
of  the rete ridges with reduced surface contact of  the epidermis 
and dermis. This results in a reduced exchange of  nutrients and 
metabolites between these two parts. In the dermis several fibro-
blasts may be seen, as well as a loss of  dermal volume [31, 60]. 
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In the study to Lavker et al., [60], the fine structural organization 
of  the epidermis, dermal/epidermal junction, and dermis from 
an unexposed site (upper inner arm) of  elderly people was com-
pared with the organization of  a similar region of  young people. 
Despite an overall thinning of  the epidermis and focal areas of  
cytologic atypia, the characteristic morphological markers associ-
ated with the keratinization process are not markedly altered in 
appearance or amount. A well formed stratum corneum consist-
ing of  flattened, enucleated horny cells enveloped by a thickened 
membrane, and intracellular spaces filled with electron-dense ma-
terial provide structural evidence that barrier ability is not com-
promised in senile skin. The dermal/epidermal changes in aged 
skin are marked and have significant physiologic implications. 
The major change is a relatively flat dermal/epidermal junction 
resulting from the retraction of  the epidermal papillae as well 
as the microprojections of  basal cells into the dermis. This flat-
tening results in a more fragile epidermal/dermal interface and, 
consequently, the epidermis is less resistant to shearing forces. 
Retraction of  the epidermal downgrowths (preferential sites of  
the putative epidermal stem cell) may also explain the loss in pro-
liferative capacity associated with the aged epidermis. The three-
dimensional arrangements of  collagen and elastic fibers showed 
marked alterations with age. Both fibrous components appear 
more compact because of  a decrease in spaces between the fib-
ers. Collagen bundles appear to unravel, and the individual elastic 
fibers show signs of  elastosis. These changes may contribute to 
the loss of  resilience that is one of  the salient features of  senile 
skin [60]. A decrease in blood supply due to a reduced number 
of  blood vessels also occurs. There is also a depressed sensory 
and autonomic innervation of  epidermis and dermis. Cutaneous 
appendages are affected as well. Terminal hair converts to vellus 
hair. As melanocytes from the bulb are lost, hairs begin to gray. 
Further reasons for graying are decreased tyrosinase activity, less 
efficient melanosomal transfer and migration, and melanocyte 
proliferation [61]. The primary distinguishing feature of  follicular 
melanogenesis, compared to the continuous melanogenesis in the 
epidermis, is the tight coupling of  hair follicle melanogenesis to 
the hair growth cycle. This cycle appears to involve periods of  
melanocyte proliferation (during early anagen), maturation (mid 
to late anagen) and melanocyte death via apoptosis (during early 
catagen). Thus, each hair cycle is associated with the reconstruc-
tion of  an intact hair follicle pigmentary unit... at least for the first 
10 cycles or so. Thereafter, gray and white hairs appear, suggesting 
an age-related, genetically regulated exhaustion of  the pigmentary 
potential of  each individual hair follicle. Melanocyte aging may 
be associated with reactive oxygen species-mediated damage to 
nuclear and mitochondrial DNA with resultant accumulation of  
mutations with age, in addition to dysregulation of  anti-oxidant 
mechanisms or pro/anti-apoptotic factors within the cells. While 
the perception of  "gray hair" derives in large part from the ad-
mixture of  pigmented and white hair, it is important to note that 
individual hair follicles can indeed exhibit pigment dilution or true 
grayness. This dilution is due to a reduction in tyrosinase activ-
ity of  hair bulbar melanocytes, sub-optimal melanocyte-cortical 
keratinocyte interactions, and defective migration of  melanocytes 
from a reservoir in the upper outer root sheath to the pigment-
permitting microenvironment close to the dermal papilla of  the 
hair bulb [61].
Factors that contribute to wrinkling include changes in muscles, 
the loss of  subcutaneous fat tissue, gravitational forces, and the 
loss of  substance of  facial bones and cartilage. Expression lines 
appear as result of  repeated tractions caused by facial muscles that 
lead to formation of  deep creases over the forehead and between 
eyebrows, and in nasolabial folds and periorbital areas. Repeated 
folding of  the skin during sleeping in the same position on the 
side of  the face contributes to appearance of  “sleeping lines.” 
Histologically, thick connective tissue strands containing muscle 
cells are present beneath the wrinkle [62]. Skin microrelief  alters 
progressively with age. Wrinkles do not result from these changes 
but are superimposed upon them. Wrinkles result from structural 
changes in the epidermis, dermis and hypodermis. Four types of  
wrinkles can be recognized. Type 1 wrinkles are atrophic. Type 
2 wrinkles are elastotic. Type 3 wrinkles are expressional. Type 4 
wrinkles are gravitational. Each type of  wrinkle is characterized 
by distinct microanatomical changes and each type of  wrinkle 
develops in specific skin regions. Each is likely to respond differ-
ently to treatment. Skin microrelief  and skin folds can be identi-
fied on histological examination. By contrast, only minimal der-
mal changes are found beneath permanent or reducible wrinkles 
compared with immediately adjacent skin [62]. In the muscles an 
accumulation of  lipofuscin (the “age pigment”), a marker of  cel-
lular damage, appears. In a study of  80 perioral muscle specimens, 
lipid pigment (Lipofuscin) granules were present in 68.5% of  the 
cases [63]. The pigmented granules, which were stored at the nu-
clear poles, were PAS positive, stained black or brown with the 
Masson-Fontana procedure, black with Sudan black and strong 
purple-pink with Ziehl-Neelsen staining; yellow autofluorescence 
was emitted in ultraviolet light. The morphology, histochemical 
reactions and autofluorescence of  the pigmented granules were 
characteristics of  the endogenous lipid pigment--lipofuscin. Sta-
tistical analyses indicated a direct correlation between increase in 
quantity and distribution of  the pigment and increase in age (p 
less than 0.0001), in both males and females [63]. The deteriora-
tion of  neuromuscular control contributes to wrinkle formation 
[63]. 
The constant gravitational force also acts on the facial skin, result-
ing in an altered distribution of  fat and sagging. Skin becomes lax 
and soft tissue support is diminished. Gravitational effects with 
advanced years play an important role and contribute to advanced 
sagging. This factor is particularly prominent in the upper and 
lower eyelids, on the cheeks, and in the neck region. Fat depletion 
and accumulation at unusual sites contributes to the altered ap-
pearance of  the face [64]. It affects the forehead, periorbital, and 
buccal areas, the inner line of  nasolabial folds, and the temporal 
and perioral regions. At the same time it accumulates submentally, 
around the jaws, at outer lines of  nasolabial folds and at lateral 
malar areas. In contrast to the young, in whom fat tissue is dif-
fusely distributed, in aged skin fat tends to accumulate in pockets, 
which droop and sag due to the force of  gravity [64, 65].
A careful study of  the aging face reveals it to be more than just 
surface textural wrinkling or loose skin. Changes in three-dimen-
sional topography are responsible for the distinctive phenotypic 
presentation of  the face throughout life. These geometric altera-
tions are secondary to apportioning in the fat compartments and 
result in the fat dysmorphism characteristic of  senescence. Redis-
tributing this fat can rebalance the facial fat compartments and 
mimic the facial structure present in youth [64]. Fat augmentation 
of  the aging face has been a popular cosmetic procedure for dec-
ades. Many consider fat the ideal filler because it is natural, nonal-
lergenic, and readily available. However, longevity and symmetry 
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of  the fat graft have been unpredictable. In addition, when large 
volumes are injected for panfacial correction, prolonged edema 
for months may result. In the study to Butterwick and Lack [65] 
one hundred patients underwent the F.A.M.I. procedure in which 
fat was injected within the muscles of  facial expression. The fat 
was harvested in an atraumatic and sterile manner. Centrifuged fat 
was then injected with specific blunt-tipped cannulae for different 
muscle groups. The majority of  patients underwent a partial- ver-
sus full-face procedure. Patients were injected with volumes rang-
ing from 3 to 63 cc of  centrifuged fat in a single session. There 
were no complications, and downtime was 5 to 7 days. Patient 
satisfaction was high. Patients were followed postoperatively for 
3 to 6 months [65].
The mass of  facial bones and skeletal bones reduces with age. 
Resorption affects the mandible, maxilla, and frontal bones. This 
loss of  bone enhances facial sagging and wrinkling with oblitera-
tion of  the demarcation between the jaw and neck that is so dis-
tinct in young persons [66]. It also seems that estrogen and pro-
gesterone contribute to elastic fiber maintenance [67]. To confirm 
this, skin signs and symptoms were examined in 46 menopausal 
women prior to estrogen replacement therapy. Several symptoms 
such as pruritus, bruising, dryness and thinning were seen more 
frequently in sun exposed skin emphasizing the contribution of  
photoaging [67]. At the end of  a 6-mth treatment period, no 
significant difference was observed in the prevalence or severity 
of  the cutaneous signs and symptoms when patients receiving 
transdermal 17 beta-estradiol (Estraderm) were compared with 
controls (the only exception was cutaneous flushing). Elastic fib-
ers from sun protected (buttock) skin of  menopausal women 
were studied by light and electron microscopy. In 3 women (ages 
30-37) with a history of  premature menopause, the elastic fibers 
had several degenerative changes including coalescence of  cystic 
spaces into lacunae, peripheral fragmentation, granular degenera-
tion and splitting of  the fibers into strands. Similar age-related 
ultrastructural changes are normally found in individuals that are 
at least 20 yrs older than these patients. These findings are sug-
gestive of  a relationship between premature aging of  the dermal 
elastic fibers and estrogen deprivation [67].
Biomarkers and Factors of  Extrinsic Aging
A number of  extrinsic, or external, factors often act together with 
the normal aging process to prematurely age our skin. Most pre-
mature aging is caused by sun exposure. Other external factors 
that prematurely age our skin are repetitive facial expressions, 
gravity, sleeping positions, and smoking. Extrinsic aging often 
develops due to several factors: ionizing radiation, severe physi-
cal and psychological stress, alcohol intake, poor nutrition, over-
eating, environmental pollution, and exposure to UV radiation. 
Among all these environmental factors, UV radiation contributes 
up to 80%. It is the most important factor in skin aging, especially 
in premature aging. Both UVB (290–320 nm), and UVA (320–400 
nm) are responsible, and the skin alterations caused by UV radia-
tion depend upon the phenotype of  photoexposed skin [30, 68].
Without protection from the sun rays, just a few minutes of  expo-
sure each day over the years can cause noticeable changes to the 
skin. Freckles, age spots, spider veins on the face, rough and leath-
ery skin, fine wrinkles that disappear when stretched, loose skin, 
a blotchy complexion, actinic keratoses (thick wart-like, rough, 
reddish patches of  skin), and skin cancer can all be traced to sun 
exposure.
UVB induces alterations mainly at the epidermal level, where the 
bulk of  UVB is absorbed. It damages the DNA in keratinocytes 
and melanocytes, and induces production of  the soluble epider-
mal factor (ESF) and proteolytic enzymes, which can be found in 
the dermis after UV exposure. UVB is responsible for appearance 
of  thymidine dimers, which are also called “UV fingerprints”. 
That is, after UVB exposure, a strong covalent bond between 
two thymidines occurs. With aging, this bond cannot be dissolved 
quickly, and accumulation of  mutations occurs. Affected cells 
appear as sunburn cells 8 to 12 hours after exposure. Reduced 
production of  DNA can be observed during the next 12 hours. 
Actinic keratoses, lentigines, carcinomas, and melanomas repre-
sent delayed effects [3]. 
“Photoaging” is the term dermatologists use to describe this type 
of  aging caused by exposure to the sun rays. The amount of  pho-
toaging that develops depends on: 1) a person’s skin color and 2) 
their history of  long-term or intense sun exposure. People with 
fair skin who have a history of  sun exposure develop more signs 
of  photoaging than those with dark skin. In the darkest skin, the 
signs of  photoaging are usually limited to fine wrinkles and a mot-
tled complexion. Photoaging occurs over a period of  years. With 
repeated exposure to the sun, the skin loses the ability to repair 
itself, and the damage accumulates. Scientific studies have shown 
that repeated ultraviolet (UV) exposure breaks down collagen and 
impairs the synthesis of  new collagen. The sun also attacks skin 
elastin. Sun weakened skin ceases to spring back much earlier than 
skin protected from UV rays. Skin also becomes loose, wrinkled, 
and leathery much earlier with unprotected exposure to sunlight. 
Photoaged skin is characterized by alterations in dermal connec-
tive tissue. The skin is increasingly exposed to ambient UV ir-
radiation thus particularly increasing its risk for photooxidative 
damage with long-term detrimental effects like photoaging, which 
is characterized by wrinkles, loss of  skin tone, and resilience. The 
amount and structure of  this tissue seems to be responsible for 
wrinkle formation. The dermal extracellular matrix consists of  
type I and III collagens, elastin, proteoglycans, and fibronectin, 
and collagen fibrils strengthen the skin. In photoaged skin, col-
lagen fibrils are disorganized and elastin-containing material accu-
mulates [68]. Levels of  precursors as well as cross-links between 
type I and III collagens are reduced, whereas elastin is increased 
[69, 70]. Braverman and Fonferko [69] studied by light and elec-
tron microscopy the elastic fibers in he sun exposed and sun pro-
tected skin of  normal and psoriatic individuals of  different ages 
in order to separate the changes of  actinic damage from those 
of  chronological aging. The sun exposed skin showed 2 types 
of  elastic fiber abnormalities-one related to actinic damage and 
the other to chronological aging. The sun protected buttock skin 
showed only the latter. From ages 30 to 70, a minority of  the 
elastic fibers exhibited abnormalities that appeared to represent a 
process of  fiber disintegration. After age 70, the majority of  elas-
tic fibers showed these abnormalities. These abnormalities were 
present without accompanying inflammatory cells. Also, there 
was morphological evidence of  continuing synthesis of  elastic 
fibers during the lifetime of  these subjects, except that from ages 
50-93, the fibers appeared to be loosely, rather than compactly, 
assembled [69]. Talwar et al., [70] quantitatively assessed the rela-
tion between type I and type III procollagen precursor levels and 
the severity of  clinical photodamage in human skin. Levels of  
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procollagen, pN collagen (collagen without the carbroxypropep-
tide), and/or pC collagen (collagen without the aminopropeptide) 
were determined by radioimmunoassay, Western blot, and immu-
nohistology in punch biopsy specimens from mildly and severely 
photodamaged forearm skin and from sunprotected underarm 
and buttock skin of  the same subjects. Collagen precursor levels 
in forearm and underarm skin were expressed relative to buttock 
levels for comparison. In the mildly photodamaged group, col-
lagen precursors in the forearm did not differ from those in the 
underarm by any measurement, except for type I collagen precur-
sors measured by radioimmunoassay, which were reduced 16%. 
In severely photodamaged forearm skin, both type I and type III 
collagen precursor levels, measured by radioimmunoassay, were 
significantly reduced (approximately 40%). 
Western analysis revealed similar significant reductions in type I 
and type III collagen precursor levels in severely photodamaged 
forearm skin compared with the sun-protected underarm. Immu-
nohistology localized both type I and III pN collagens predomi-
nantly to the extracellular papillary dermis. Relative staining in-
tensities of  type I and type III pN collagen were also significantly 
reduced in severely photodamaged forearm skin. Multiple linear 
regression modeling of  all data demonstrated that reductions in 
collagen precursor levels were significantly correlated (p < 0.03) 
with the severity of  photodamage, but not with chronologic age. 
These data demonstrate, by three independent methods, coor-
dinate reductions of  both type I and type III collagen precur-
sors in photodamaged human skin, and the degree of  reduction 
correlated with the degree of  photodamage. It is likely that such 
changes in collagen precursors lead to reduced levels and/or al-
tered organization of  fibrillar collagen, and thus may contribute 
to the wrinkled appearance of  photodamaged human skin [70]. 
Type I and type III procollagen are reduced in photodamaged 
human skin. This reduction could result from increased degrada-
tion by metalloproteinases and/or from reduced procollagen syn-
thesis. In the separate study, Varani et al., [71] investigated type I 
procollagen production in photodamaged and sun-protected hu-
man skin. Skin samples from severely sun-damaged forearm skin 
and matched sun-protected hip skin from the same individuals 
were assessed for type I procollagen gene expression by in situ 
hybridization and for type I procollagen protein by immunostain-
ing. Both mRNA and protein were reduced (approximately 65 
and 57%, respectively) in photodamaged forearm skin compared 
to sun-protected hip skin. We next investigated whether reduced 
type I procollagen production was because of  inherently reduced 
capacity of  skin fibroblasts in severely photodamaged forearm 
skin to synthesize procollagen, or whether contextual influences 
within photodamaged skin act to down-regulate type I procolla-
gen synthesis. For these studies, fibroblasts from photodamaged 
skin and matched sun-protected skin were established in culture. 
Equivalent numbers of  fibroblasts were isolated from the two 
skin sites. Fibroblasts from the two sites had similar growth ca-
pacities and produced virtually identical amounts of  type I pr-
ocollagen protein. These findings indicate that the lack of  type 
I procollagen synthesis in sun-damaged skin is not because of  
irreversible damage to fibroblast collagen-synthetic capacity. It 
follows, therefore, that factors within the severely photodamaged 
skin may act in some manner to inhibit procollagen production by 
cells that are inherently capable of  doing so. Interactions between 
fibroblasts and the collagenous extracellular matrix regulate type 
I procollagen synthesis. In sun-protected skin, collagen fibrils ex-
ist as a highly organized matrix. Fibroblasts are found within the 
matrix, in close apposition with collagen fibers. In photodamaged 
skin, collagen fibrils are shortened, thinned, and disorganized. 
The level of  partially degraded collagen is approximately 3.6-fold 
greater in photodamaged skin than in sun-protected skin, and 
some fibroblasts are surrounded by debris. To model this situa-
tion, skin fibroblasts were cultured in vitro on intact collagen or 
on collagen that had been partially degraded by exposure to col-
lagenolytic enzymes. Collagen that had been partially degraded by 
exposure to collagenolytic enzymes from either bacteria or human 
skin underwent contraction in the presence of  dermal fibroblasts, 
whereas intact collagen did not. Fibroblasts cultured on collagen 
that had been exposed to either source of  collagenolytic enzyme 
demonstrated reduced proliferative capacity (22 and 17% reduc-
tion on collagen degraded by bacterial collagenase or human skin 
collagenase, respectively) and synthesized less type I procollagen 
(36 and 88% reduction, respectively, on a per cell basis). 
Taken together, these findings indicate that 1) fibroblasts from 
photoaged and sun-protected skin are similar in their capacities 
for growth and type I procollagen production; and 2) the accu-
mulation of  partially degraded collagen observed in photodam-
aged skin may inhibit, by an as yet unidentified mechanism, type I 
procollagen synthesis [71].
Photoaged skin displays prominent alterations in the cellular 
component and the extracellular matrix of  the connective tissue 
with an accumulation of  disorganized elastin and its microfibrillar 
component fibrillin and other constituents of  elastin-associated 
microfibrils in the deep dermis, and a severe loss of  interstitial 
collagens, the major structural proteins of  the dermal connec-
tive tissue. The unifying pathogenic agents for these changes 
are UV-generated ROS that deplete and damage non-enzymatic 
and enzymatic antioxidant defense systems of  the skin. As well 
as causing permanent genetic changes, ROS activate cytoplas-
mic signal transduction pathways in resident fibroblasts that are 
related to growth, differentiation, senescence, and connective 
tissue degradation [68]. It is accepted that UVA radiation plays 
an important role in the pathogenesis of  photoaging [72]. UVA 
penetrates more deeply into the dermis and damages both the 
epidermis and dermis. The amount of  UVA in ambient light ex-
ceeds the UVB by 10 to 100 times, but UVB has biological effects 
1,000 times stronger than UVA [3]. There is increasing evidence 
for the generation of  ROS in skin upon ultraviolet exposure, but 
little is known about their pathophysiologic relevance in human 
skin in vivo. Sander et al., [73] proposed that chronic and acute 
photodamage is mediated by depleted antioxidant enzyme ex-
pression and increased oxidative protein modifications. Biopsies 
from patients with histologically confirmed solar elastosis, from 
non-ultraviolet-exposed sites of  age-matched controls, and from 
young subjects were analyzed. To evaluate the influence of  acute 
ultraviolet exposures, buttock skin of  12 healthy subjects was ir-
radiated repetitively on 10 d with a solar simulator and compared 
intraindividually to non-ultraviolet treated contralateral sites. The 
antioxidant enzymes catalase, copper-zinc superoxide dismutase, 
and manganese superoxide dismutase were investigated by im-
munohistochemistry. Protein carbonyls were analyzed by immu-
nohistochemical and immunoblotting techniques in human skin 
and in cell models. Whereas overall expression of  antioxidant 
enzymes was very high in the epidermis, low baseline levels were 
found in the dermis. In photoaged skin, a significant depletion of  
antioxidant enzyme expression was observed within the stratum 
corneum and in the epidermis. Importantly, an accumulation of  
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oxidatively modified proteins was found specifically within the 
upper dermis of  photoaged skin. Upon acute ultraviolet exposure 
of  healthy subjects, depleted catalase expression and increased 
protein oxidation were detected. Exposures of  keratinocytes and 
fibroblasts to ultraviolet B, ultraviolet A, and H2O2 led to dose-
dependent protein oxidation and thus confirmed in vivo results 
[73]. A decrease in the overall ROS load by efficient sunscreens 
or other protective agents may represent promising strategies to 
prevent or at least minimize ROS induced photoaging [68].
UV induces the matrix metalloproteinases collagenase, 92-kD ge-
latinase, and stromelysin, which degrade skin connective tissue 
and may contribute to premature skin aging (photoaging) [74]. 
UV radiation increases the production of  collagen-degrading en-
zymes, matrix metalloproteinases (MMPs), and the xeroderma 
pigmentosum factor (XPF), which can also be found in the epi-
dermis. XPF induces epidermal-dermal invagination, represent-
ing the beginning of  wrinkle formation. At the base of  wrinkles, 
less type IV and VII collagen is found. This instability deepens 
the wrinkles. Each MMP degrades a different dermal matrix pro-
tein; for example, MMP-1 cleaves collagen types I, II, and III, and 
MMP-9 (gelatinase) degrades type IV and V and gelatin. Under 
normal conditions, MMPs are part of  a coordinated network and 
are regulated by their endogenous inhibitors (TIMPs). The im-
balance between activation and inhibition can lead to proteolysis 
[74].
Chronic sun exposure can result in numerous changes in hu-
man skin, particularly the skin of  fair-skinned individuals. These 
changes include wrinkling, elastosis, actinic keratoses, irregular 
pigmentation, telangiectasia, and skin cancer. Most of  these al-
terations had formerly been considered to be caused by UVB 
wavelengths, which are the wavelengths probably most responsi-
ble. However, a number of  recent studies have demonstrated that 
UVA can also cause burning, elastosis, and skin cancer [75]. The 
activation of  MMPs can be triggered by UVA and UVB, but mo-
lecular mechanisms differ depending upon the type of  radiation. 
UVA radiation can generate ROS that affect lipid peroxidation 
and generate DNA strand breaks [75]. On the other hand, within 
minutes after exposure UVB radiation causes MMP activity and 
DNA damage. These effects can be observed after exposing hu-
man skin to one-tenth of  the minimal erythema dose.
Smoking and smog as environmental factors of  skin aging
Another environmental factor contributing to premature aging is 
smoking. Tobacco smoking is a serious and preventable health 
hazard that can cause or exacerbate a number of  diseases and 
shorten life expectancy, but the role of  smoking as an etiologic 
factor in the development of  skin disease is largely unknown. To-
bacco smoke contains a complex mixture of  gaseous and par-
ticulate compounds, several of  which may have the potential to 
exert physiologic and pharmacologic impacts (Figure 6). Nico-
tine has for decades been regarded as a primary factor that en-
genders smoking-related disorders, but recent evidence clearly 
demonstrates that its temporary vasoactive effect on the skin and 
subcutaneous perfusion cannot satisfactorily explain the patho-
physiologic mechanisms that impair wound healing and contrib-
ute to smoking-related disorders [76]. Although epidemiological 
evidence is sparse, findings suggest that tobacco smoking is a con-
tributing factor in systemic lupus erythematosus, psoriasis, palmo-
plantar pustulosis, cutaneous squamous cell carcinoma, hidradeni-
tis suppurativa, and genital warts [77]. In contrast, smoking may 
confer some protective effects and mitigate other skin diseases, 
notably pemphigus vulgaris, pyoderma gangrenosum, aphthous 
ulcers, and Behçet's disease. Various degenerative dermatologic 
conditions are also impacted by smoking, such as skin wrinkling 
and dysregulated wound healing, which can result in post-surgical 
complications and delayed or even arrested healing of  chronic 
wounds. Most likely, alteration of  inflammatory cell function and 
extracellular matrix turnover caused by smoking-induced oxida-
tive stress are involved in the pathophysiologic mechanisms [77]. 
Figure 6. Smoker’s face skin.
"Smoker’s Face" was defined as one or more of  the following:
a. lines or wrinkles on the face, typically radiating at right angles from the upper and lower lips or corners of  the eyes, deeplines on the 
cheeks, or numerous shallow lines on the cheeks and lower jaw.
b. A subtle gauntness of  the facial features with prominence of  the underlying bony contours. Fully developed this change gives the face 
and ‘atherosclerotic’ (sic. A bit like choked up blood vessels) look; lesser changes show as slight sinking of  the cheeks. In some cases these 
changes are associated with a leathery, worn, or rugged appearance.
c. An atrophic, slightly pigmented grey appearance of  the skin.
d. A plethoric, slightly orange, purple and red complexion different from the purply blue colour of  cyanosis or the bloated appearance 
associated with the pseudo-Cushing’s changes of  alcoholism".
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“Smoker’s face” or “cigarette skin” are characteristic, implying 
increased facial wrinkling and an ashen and gray skin appear-
ance [78]. Cigarette smoking is strongly linked to serious inter-
nal diseases such as cancer, cardiovascular disease, and lung dis-
ease. However, the external manifestations and consequences of  
smoking are relatively unknown. Although generally less ominous, 
the cutaneous manifestations of  smoking may be associated with 
significant morbidity [77]. Smoking produces systemic immu-
nomodulatory effects through the release of  ROS from tobacco 
smoke, which is believed to cause a cascade of  detrimental effects 
on normal inflammatory cell function by attenuating phagocytosis 
and bactericidal mechanisms, as well as by increasing the release 
of  proteolytic enzymes [79, 80]. In addition, collagen synthesis 
and the deposition of  mature collagen in the extracellular matrix 
are reduced through smoking [81]. Because mature collagen is the 
main determinator of  strength of  an operative wound, the results 
support the view that patients should be advised to stop smok-
ing before an operation [81]. Such disruptive influences on these 
biologic mechanisms culminate in adverse affects on the cellular 
reparative pathways of  the skin and its appendages, which can be 
observed in the healing of  acute wounds in smokers. This co-
hort has a significantly higher risk of  post-operative dehiscence 
and infection, and in patients who are heavy smokers, slowed 
or arrested healing of  chronic wounds can also occur [82]. Un-
doubtedly, degenerative skin disorders are the result of  smoking-
induced defects in reparative mechanisms and the progression of  
extracellular degradation of  elastin, collagen, and other extracel-
lular matrix molecules. More complex, and in fact unknown, is the 
role of  smoking in the etiology of  autoimmune and neoplastic 
skin diseases. It is increasingly apparent that the immunomodu-
latory effects and alteration of  inflammatory cell function from 
smoking influences the clinical course of  cutaneous diseases. 
Dermatologic research still needs to elucidate why smoking is an 
aggravating factor for some diseases, while appearing to mitigate 
the clinical course of  others. A prematurely old appearance is a 
symptom of  long-term smokers. Yellow and irregularly thickened 
skin is result of  elastic tissue breakdown due to smoking [83] or to 
UV. While strategies for framing messages about the association 
between smoking and facial aging await further study, this associa-
tion deserves to be considered in all tobacco control and counter-
advertising campaigns. Although the tobacco industry promotes 
images of  glamour, 2 decades of  epidemiologic research have 
concluded the opposite: smokers have enhanced facial aging and 
skin wrinkling compared with nonsmokers [83]. Although there 
are methodological concerns with each of  these studies, the data 
are consistent with the conclusion that smoking causes skin wrin-
kling that could make smokers appear unattractive and prema-
turely old [84]. Cigarette smoking has been shown to decrease 
capillary and arteriolar blood flow in the skin, perhaps damaging 
connective tissue components that are important to maintaining 
the integrity of  the skin. Americans are highly motivated to avoid 
or eliminate facial wrinkles. The association of  smoking and facial 
wrinkling may be important evidence to convince young persons 
not to begin smoking and older smokers to quit [84]. It seems that 
cigarette smoking induces the activation of  MMPs in the same 
mode as in persons with significant sun exposure [85]. Lahmann 
et al., [85] have compared the concentrations of  mRNA for matrix 
metalloproteinase 1 (MMP-1) in the buttock skin of  smokers and 
non-smokers with quantitative real-time polymerase chain reac-
tions. MMP-1 degrades collagen, which accounts for at least 70% 
of  the dry weight of  dermis. We report significantly more MMP-
1 mRNA in the skin of  smokers than non-smokers whereas no 
difference was seen for the tissue inhibitor of  metalloproteinases 
1 (TIMP-1) or the housekeeping gene GAPDH (glyceraldehyde-
3-phosphate dehydrogenase). The authors suggest that smoking-
induced MMP-1 might be important in the skin ageing effects of  
tobacco smoking [85]. Smoking also reduces facial stratum cor-
neum moisture as well as vitamin A levels, which is important in 
reducing the extent of  collagen damage [30].
The photochemical activity of  smog is due to the reduction of  
air pollutants such as nitrogen oxides and volatile organic com-
pounds created from fossil fuel combustion in the presence of  
sunlight. Emission from factories and motor vehicle exhaust are 
primary sources of  these compounds. The major targets of  ozone 
in the skin are the superficial epidermal layers; this results in the 
depletion of  antioxidants such as alpha-tocopherol (vitamin E) 
and ascorbic acid (vitamin C) in the superficial epidermal layers 
[86].
As stochastic damage is explained, the damage is initiated by ran-
dom cosmic radiation and triggered by free radicals during cell 
metabolism, which damages cell lipid compounds, especially 
membrane structures [3, 87].
Therapeutic Solutions to Improve Aging Skin. In-
novative Oral Therapeutic Dosage Forms of  Non-
Hydrolized Carnosine and Carcinine are Acting 
for Skin Beautification and Rejuvenation Through 
the Protective Telomere -Mediated Treatment Ef-
fects on Dermal Fibroblasts
Medical and procedural interventions are available to improve 
aging skin (reviewed in ref. [12]). Medical interventions typically 
refer to topical agents that will prevent sun damage or stimulate 
the production of  new collagen. These treatments are long-term 
solutions, and the results, although measurable, can be subtle and 
occur over fairly long periods of  time. Medical treatments focus 
mainly on the issue of  abnormal collagen; such treatments in-
clude the use of  topical retinoids, select antioxidants, and, more 
recently, drugs that are used primarily to resolve precancerous 
skin lesions known as actinic keratoses. Medical treatments are 
usually in the form of  prescription medications, but some are 
available as over-the-counter preparations.
Procedural treatments, on the other hand, tend to lead to more 
dramatic changes, and the effects are noted sooner than with 
medical therapy alone. These procedures are often employed in 
conjunction with medical therapy to combat the effects of  aging 
skin. Procedures such as laser surgery can address dyspigmenta-
tion, redness, and textural changes. Soft tissue fillers address the 
volume loss associated with aging. Botulinum toxin injections are 
used to treat dynamic wrinkles associated with repeated muscle 
movement and that ultimately lead to “fixed” wrinkles at rest. 
These procedures are administered by trained professionals and 
can be associated with significant side effects [12]. 
Oral peptide delivery platform of  non-hydrolized carnosine 
or carcinine addressing skin aging problems
A growing body of  research is showing how nutricosmetics can 
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contribute to healthy skin. While topical creams and cosmetic 
products can affect skin condition from the outside, nutritional 
supplements taken orally can have an impact from within the skin: 
this is called “Beauty from Within”.
Carnosine (β-alanyl-L-histidine) and related compounds are natu-
ral constituents of  excitable tissues possessing diverse biological 
activities [88, 89]. The level of  carnosine in tissues is controlled 
by a number of  enzymes transforming carnosine into other car-
nosine related compounds, such as carcinine, N-acetylcarnosine, 
anserine or ophidine (by decarboxylation, acetylation or methyla-
tion, respectively) or its cleavage into the amino acids, histidine 
and β-alanine. Hydrolysis is mainly due to tissue carnosinase (EC 
3.4.13.3) which is widely distributed among different subjects [44, 
90, 91] or serum carnosinase (EC 3.4.13.20), present in brain and 
blood plasma of  primates and humans [44, 92, 93]. Carnosine has 
been proven to scavenge ROS as well as alpha-beta unsaturated 
aldehydes formed from peroxidation of  cell membrane fatty acids 
during oxidative stress [94, 95]. It can oppose glycation [96, 97] 
and it can chelate divalent metal ions [98]. The important stud-
ies have produced clinical and experimental evidence of  benefi-
cial effects of  N-acetylcarnosine in treating cataracts of  the eyes, 
these and other ophthamological benefits have been proven [99-
109]. Carcinine (β-alanyl histamine) is an imidazole dipeptide first 
discovered in the crustacean Carcinus maenas [Reviewed in refs. [44, 
89, 110] , and has subsequently been found in the hearts of  several 
mammalian species [111, 112]. It has been demonstrated that car-
cinine is metabolically related to histamine, histidine, and carnos-
ine (β-alanyl histidine), and could be synthesized from histamine 
and β-alanine [113]. In addition, previous studies have shown that 
carcinine contains an imidazole group with flexible ethylene side 
chain known to be important for histamine H3 receptor-ligand 
interactions [114-117]. From these findings, it seems that a cer-
tain relationship exists between brain histamine and carcinine, 
and that carcinine might be a new histamine H3 receptor antago-
nist. The results of  the recent study provide direct evidence that 
carcinine, as a novel histamine H3 receptor antagonist, plays an 
important role in histaminergic neurons activation and might be 
useful in the treatment of  certain diseases, such as epilepsy, and 
locomotor or cognitive deficit [118]. In two of  the reports, carci-
nine was shown to act as a natural antioxidant [119, 120] and to 
play a role in regulating stress and shock with a 1000-fold less po-
tent hypotensive effect than histamine [112, 121], suggesting that 
carcinine might have therapeutic use (reviewed in Ref. [122, 123]). 
Overall, these low molecular mass antioxidant peptidomimetics 
add significantly to the host defense provided by the enzymes su-
peroxide dismutase, catalase and glutathione peroxidases and act 
as pharmacological chaperones in biological systems [44, 89, 119, 
120, 123]. 
Innovative Vision Products, Inc. (IVP) metabolic scientists have 
validated an oral drug delivery platform of  non-hydrolized carno-
sine and are in the process of  validating a drug delivery platform 
for carcinine which could be used to redesign existing injected 
peptides to enable oral uptake. This technology is based on an 
understanding of  the dipeptide structure stabilization from the 
enzymatic hydrolysis with carnosinases during the oral delivery 
of  a peptide drug which was found to be inherently orally avail-
able (can be swallowed rather than injected or topically applied 
to the skin with a cream) [40, 41]. The vast majority of  peptides 
(fragments of  proteins, or very small proteins) are broken apart 
by digestive enzymes or acid in the stomach and intestines before 
they have a chance to be absorbed into the body tissues, so most 
peptide drugs cannot be taken by the patient preferred oral route 
and are usually injected. The injected route of  administration usu-
ally limits the commercial value of  peptide drugs, even though 
they can be very effective drugs with good safety and tolerability 
profiles, because their design is often based on natural molecules. 
The ability to convert any of  these peptides to oral drugs could 
have significant commercial value. Delivery of  peptide drugs or 
peptide cosmetic ingredients through the skin is an attractive al-
ternative to needles, but has proved elusive thus far. The rewards 
for effective transdermal drug delivery of  peptides are large. Drug 
delivery using skin patches has grown into a multibillion dollar in-
dustry, with multiple commercial and clinical successes for a vari-
ety of  small drugs. Patients like patches because of  their conveni-
ence - there is no need to remember to take frequent pills and no 
pain from hypodermic injections. Doctors like patches because 
of  their efficacy - transdermal delivery avoids the complications 
of  poor absorption and enzymatic degradation associated with 
oral delivery and eliminates the peaks and valleys of  drug concen-
tration in the blood associated with bolus injections. And phar-
maceutical companies like patches because of  their profitability-
patches are not only preferred by their customers but can often be 
used, in effect, to extend the patent life of  a drug through new and 
improved delivery. These advantages have motivated the research 
community to overcome the primary challenge of  transdermal 
delivery: however, the skin's outer layer of  stratum corneum is 
an extremely tough barrier for peptide compounds, that gener-
ally only permits entry of  small, lipophilic drugs and uniformly 
excludes large, hydrophilic proteins. Various chemical enhancers, 
such as surfactants, have been used to increase skin permeability 
to small molecules but, with few exceptions, have been ineffec-
tive in delivering proteins. Physical approaches, which breach the 
skin's barrier more aggressively, have recently met with some suc-
cess for proteins and other compounds. Electric fields, ultrasound 
and jet injectors have received US Food and Drug Administra-
tion approval for transdermal applications, and microneedles and 
thermal ablation are being studied in clinical trials. Although these 
methods show promise, they may be limited by the need for de-
vices that could be large, costly and cumbersome [123, 124].
A range of  candidate compounds in the oral formulation of  non-
hydrolized carnosine have been screened [40-43, 125, 126] and 
fine-tuned to identify the most promising candidates for potential 
development as an orally dosable drug or therapeutic nutritional 
product for the treatment of  skin aging supported by morphom-
etry (computerized image analysis). Skin aging is usually accompa-
nied by the increase with age of  the surface density of  elastin 
fibers and by a corresponding decrease of  elasticity [126]. The 
clinical data with the oral formulations of  non-hydrolized carno-
sine for the skin beautification provide proof-of-concept thera-
peutic platform that tackles these disturbances of  the skin and 
application of  this technology to other interesting biomedical ap-
plications is now underway [40-43, 125, 126]. To assess the effi-
cacy and acceptability of  the oral products including imidazole-
containing dipeptide based compounds (non-hydrolized carnosine 
or carcinine), a double-blind randomized clinical study versus 
placebo was carried out [126]. A 4-month randomized double-
blind controlled study was undertaken including 42 subjects 
where the oral supplement of  non-hydrolized carnosine (Can-C 
Plus® formulation) (Figure 7) was tested against placebo for 3 
months followed by a 1-month supplement-free period for both 
groups to assess lasting effects. Assessment of  the age-related 
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Figure 7. Nutritional formulation of  non-hydrolized in digestive tracts and blood natural carnosine peptide (carnisine) as a 
panacea of  tomorrow for therapeutic protection of  smokers preventing telomeres from attrition, effective in the treatment 
of  smoking - associated disorders and controlling the cumulative oxidative stress. Non-hydrolized carnosine (carnisine) 
exerts the signaling activity attenuating nitric oxide production and inhibits inflammatory response and tissue damage in 
the respiratory tract due to the intrinsic fundamantal properties of  L-carnosine including direct NO-trapping ability and
directly by modulating cytokine release. This oral formulation of  ingredients represents stable synergistic mimics of  the 
biologically active carnosine (combination of  pharmacological chaperones) suitable for therapeutic applications and man-
agement of  the smoking-associated diseases [40, 41]. The following claim and related claims of  the invention protect the 
features of  stabilization of  carnosine and related compounds from the enzymatic hydrolysis [40, 41]:
Use of  a combination of  a carnosinase inhibitor with L-carnosine or its related substance which is a substrate of  carnosinase, for 
manufacturing a pharmaceutical or nutritional composition for increasing the carnosine or its related substance in plasma or cells of  
mammals.
wherein at least one of  the carnosinase inhibitors is used selected from the group comprising of
1. β-alanine
2. β-alanine comprising compound,
3. an N-alkanoyl-β-alanine compound
4. N-alkanoyl-L-carnosine compound
5. bestatin presented by the pharmaceutically acceptable formula of  bestatin
6. an α-amino acid derivative acting as inhibitor of  carnosinase activity and/or a dipeptidase activity, specific to hydrolize β-alanyl-
containing dipeptides (carnosine related compounds),
7. a γ- amino acid derivative, acting as carnosinase inhibitor of  a dipeptidase activity, specific to hydrolize β-alanyl-containing 
dipeptides(carnosine related compounds),
8. a thiol containing reducing agent essentially comprising unithiol, dithiothreitol, 2 mercaptoethanol, N-acetylcysteine or related 
compounds acting as a thiol type reducing agent,
9. a thiol antioxidant,
10. a metal chelating agent,
11. a hydrophobic compound with a branched hydrocarbon residue having a carnosinase inhibitor activity,
12. a manganese ion and
13. a zinc ion, or a synergistic combination thereof, in an amount and composition thereof  effective to stabilize L-carnosine and its 
said related substance from enzymatic hydrolysis in the body under preservation of  a residual carnosinase activity.
Supplemental Facts:
Serving Size: 3 capsules
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D-pantethine 90mg 894%
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Note: Keep in cool dark conditions, out of  the reach of  children and consume before end of  expiry date. Not for use by pregnant or 
lactating women.
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skin parameters and oral treatment efficacy measurements includ-
ed objective skin surface evaluation with Visioscan® VC 98 and 
visual assessment of  skin appearance parameters. The results to-
gether confirm that a direct 1-electron transfer between a Schiff  
base methylglyoxal dialkylimine (or its protonated form) and 
methylglyoxal is responsible for the generation of  the cross-linked 
radical cation and the radical counteranion of  methylglyoxal. Un-
der aerobic conditions, molecular oxygen can then accept an elec-
tron from the methylglyoxal anion to generate the superoxide 
radical anion causing the propagation of  oxidative stress chain 
reactions in the presence of  transition metal ions. Carnosine sta-
bilized from the enzymatic hydrolysis, arcinine and leucyl histydyl-
hidrazide in patented formulations thereof  demonstrate the 
Schiff  bases transglycating activities concomitant with glycation 
site specific antioxidant activities and protection of  proprietary 
antioxidant enzymes in the skin during aging and diabetes lesions. 
During oral supplementation of  stabilized from enzymatic hy-
drolysis carnosine (Can-C Plus® formulation), skin investigated 
parameters showed a continuous and significant improvement in 
the active group during the 3 months of  supplementation as com-
pared to placebo. Visual investigation showed improvement of  
the overall skin appearance and reduction of  fine lines. No treat-
ment-related side effects were reported [126]. The finding that 
already-formed Advanced glycation Maillard reaction end prod-
ucts (AGE) crosslinks can be pharmacologically severed and at-
tendant pathology thereby reversed by non-hydrolized carnosine 
or carcinine in patented oral formulations thereof  has broad im-
plications for the skin beautification and therapeutics of  the com-
plications of  diabetes and skin diseases associated with aging. A 
striking anti-senescence effect of  carnosine was demonstrated by 
McFarland and Holliday [127-129]. They showed that human dip-
loid fibroblasts grown in 20 mM carnosine had an extended lifes-
pan, both in population doublings and chronological time. The 
published study [127] has detalized that dipeptide L-carnosine has 
beneficial effects on cultured human fibroblasts. Physiological 
concentrations in standard media prolong their in vitro lifespan 
and strongly reduce the normal features of  senescence. Late pas-
sage cells in normal medium are rejuvenated when transferred to 
medium containing carnosine, and become senescent when car-
nosine is removed. In the absence of  pyruvate, carnosine is cyto-
toxic to neoplastic and transformed human and rodent cells. Mc-
Farland and Holliday [128] have examined the effects of  the 
naturally occurring dipeptide carnosine (beta-alanyl-L-histidine) 
on the growth, morphology, and lifespan of  cultured HDFs. With 
humanforeskin cells, HFF-1, and fetal lung cells, MRC-5, McFar-
land and Holliday have shown that carnosine at high concentra-
tions (20-50 mM) in standard medium retards senescence and re-
juvenates senescent cultures. These late-passage cultures preserve 
a nonsenescent morphology in the presence of  carnosine, in 
comparison to the senescent morphology first described by Hay-
flick and Moorhead (reviewed in ref. [128]). Transfer of  these late-
passage cells in medium containing carnosine to unsupplemented 
normal medium results in the appearance of  the senescent phe-
notype. The serial subculture of  cells in the presence of  carnosine 
does not prevent the Hayflick limit to growth, although the lifes-
pan in population doublings as well as chronological age is often 
increased. This effect is obscured by the normal variability of  hu-
man fibroblast lifespans, which McFarland and Holliday have 
confirmed. Transfer of  cells approaching senescence in normal 
medium to medium supplemented with carnosine rejuvenates the 
cells but the extension in lifespan is variable. Neither D-carnosine, 
(beta-alanyl-D-histidine), homocarnosine, anserine, nor beta-ala-
nine had the same effects as carnosine on human fibroblasts. Car-
nosine is an antioxidant, but it is more likely that it preserves cel-
lular integrity by its effects on protein metabolism. The muscle 
and brain-associated dipeptide, carnosine, is an intracellular buffer 
which can delay senescence in cultured human fibroblasts and de-
lay aging in senescence-accelerated mice. The effect of  advanced 
glycation end products (AGE-s) was studied on the proliferation 
and cell death of  human skin fibroblasts in culture. Several AGE-
products were prepared from proteins, a peptide and amino acids, 
using Glucose or Fructose, with or without Fe2+. The AGE prep-
arations increased cell death at the 7th day, after only 72 hours of  
incubation. Some of  these glycation products modified also pro-
liferation. This effect of  AGE-s was even maintained without 
these products in fresh medium for a second period of  incubation 
up to 10 days from the start of  the experiment. In order to ex-
plore the role of  AGE-receptors, especially of  AGE-receptor and 
of  growth factor receptors (fibroblast and epidermal growth fac-
tors receptors), antibodies to these receptors were added to cell 
cultures and their effect on both cell death and proliferation were 
determined as for the AGE-s. These anti-receptor antibodies imi-
tated to some extent the results obtained with AGE-s, producing 
increase of  cell death and proliferation, followed above a certain 
concentration of  antibodies by a decrease and a new increase or 
plateau. This might correspond to the internalization of  the re-
ceptors followed by a re-expression on the cell membrane. The 
role of  receptor-mediated ROS- production was also explored us-
ing scavengers: N-acetyl-cysteine (NAC), L-Carnosine, superox-
ide dismutase (SOD) and Catalase. Several of  these scavengers 
decreased cell death, suggesting that ROS-production is partially 
involved in the observed phenomena [130]. Carnosine's ability to 
react with methylglyoxal (MG) and possibly other deleterious car-
bonyl compounds, and scavenge various ROS, may account for its 
protective ability towards ischemia and ageing [126, 131]. At the 
cellular level 20 mM carnosine protected cultured human fibro-
blasts and lymphocytes, Chinese hamster ovary (CHO) cells, and 
cultured rat brain endothelial cells against the toxic effects of  for-
maldehyde, acetaldehyde and malonic dialdehyde (MDA), and 
AGEs formed by a lysine/deoxyribose mixture [132]. A mouse 
model was used to investigate whether tumor growth in vivo can 
be inhibited by carnosine. Therefore, NIH3T3 fibroblasts, condi-
tionally expressing the human epidermal growth factor receptor 2 
(HER2/neu), were implanted into the dorsal skin of  nude mice, 
and tumor growth in treated animals was compared to control 
mice [133]. In two independent experiments nude mice that re-
ceived tumor cells received a daily intra peritoneal injection of  500 
microl of  1 M carnosine solution. Measurable tumors were de-
tected 12 days after injection. Aggressive tumor growth in control 
animals, that received a daily intra peritoneal injection of  NaCl 
solution started at day 16 whereas aggressive growth in mice treat-
ed with carnosine was delayed, starting around day 19. A signifi-
cant effect of  carnosine on tumor growth was observed up to day 
24. Although carnosine was not able to completely prevent tumor 
growth, a microscopic examination of  tumors revealed that those 
from carnosine treated animals had a significant lower number of  
mitosis (p < 0.0003) than untreated animals, confirming that car-
nosine affects proliferation in vivo. As a naturally occurring sub-
stance with a high potential to inhibit growth of  malignant cells in 
vivo, carnosine should be considered as a potential anti-cancer 
drug [133]. Two-dimensional electrophoretic gel profiles were 
compared between rat 3Y1 fibroblasts cultured in the presence 
and absence of  30 mM L-carnosine (beta-alanyl-L-histidine) for 
one week without any replenishment of  medium. While a number 
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of  cellular proteins changed their expression levels by the addi-
tion of  carnosine, Ikeda et al., [134] identified one of  the most 
prominently varied proteins as vimentin. Immunoblot analysis 
with anti-vimentin antibody demonstrated that the vimentin lev-
els increased about 2-fold after one-week culture in the presence 
of  carnosine. Ikeda et al., [134] also confirmed that the increase 
of  vimentin expression was dependent on the concentration of  
carnosine added to the medium. Moreover, when cultured cells 
were stained with anti-vimentin antibody and observed by light 
microscopy, most cells grown in the presence of  carnosine were 
found to have markedly developed vimentin filaments. The in-
crease of  vimentin expression was also observed by adding with 
carnosine related dipeptides, N-acetylcarnosine and anserine 
[134]. Using three different experimental approaches (microscop-
ic, flow cytometric and ELISA for one of  the markers of  DNA 
oxidative damage) the study on rat embryonic fibroblasts [135] 
has demonstrated that L-carnosine at 30 mM concentration sus-
tains the retention of  cell morphology even during a nutritional 
insult for five weeks. Also, L-carnosine significantly reduces the 
formation of  8-hydroxy deoxyguanosine (8-OH dG) in the cells 
after four weeks of  continuous culture. Thus it could be inferred 
that the anti-senescent effect of  L-carnosine to fibroblasts is 
probably linked to its inhibition of  formation of  intracellular 
8-OH dG during oxidative stress [135]. An enhancing effect of  
L-histidine (L-His) was detected on the induction by hydrogen 
peroxide (H2O2) of  chromosomal aberrations of  both the chro-
mosome type and the chromatid type, in human embryonic fibro-
blasts [136]. The maximum efficiency of  induction was about 
8-fold higher in the presence of  L-His than in the presence of  
H2O2 alone, at a concentration of  L-His of  50 microM. D-His 
and DL-His showed lower enhancing effects than L-His, with ap-
proximately 2-fold and 5-fold enhancement of  induction of  chro-
mosomal aberrations, respectively. L-Histidinol and L-His-methyl 
ester, among various derivatives of  L-His tested, also enhanced 
this process. However, the effects of  these derivatives were small-
er than those of  L-His in a range of  concentrations equivalent to 
that of  the most effective dose of  L-His (50 microM), while they 
produced greater enhancement than L-His at concentrations 
higher than 200 microM. The results indicate that at least both the 
imidazole ring and the amino group are essential components of  
the chemical structure of  L-His required for the enhancing effect. 
Moreover, in order to cause such an enhancing effect, L-His had 
to be applied together with H2O2 to cells, because the enhancing 
effect of  L-His was not observed with cells which were washed 
after pretreatment with L-His. The preliminary study suggested 
that this enhancing effect depends on the His-peroxide adduct 
derived from L-His and H2O2. None of  the amino acids tested 
other than His produced any enhancing effect on the induction 
of  chromosomal aberrations by H2O2 [136].
Our own studies of  the effects of  L-carnosine on human bone 
marrow stromal cell proliferation supportingly demonstrate that 
L-carnosine increases a proliferative potential of  the human bone 
marrow cells up to three population doublings, the phenomenon 
that can be further exploited in rejuvenation and resuscitation cel-
lular and tissue engineering studies (Figure 8). It was shown that 
intake of  carnosine in a dose of  50-100 mg/kg of  body weight 
before X-ray irradiation resulted in an increase of  the survival of  
experimental mice. The protective effect of  carnosine was mani-
fested, when it was injected either before or after irradiation, but 
the effect was more pronounced in the case of  shortening time 
between irradiation and injection. An enhancement of  colony 
forming index of  bound cells in spleen was also observed simul-
taneously with protective action of  carnosine [137].
Figure 8. The effect of  L-carnosine on human bone marrow stromal cell proliferation . Primary culture Ko10.
L-Carnosine increases a proliferative potential of  the human bone marrow cells up to three population doublings, this fundamental 
phenomenon can be exploited in further rejuvenation and resuscitation studies in cellular cultures and organism aging.
The images comparatively document that in the presence of  10 mM of  L-carnosine (right image) cells of  primary culture are able to 
perform more cell divisions. Bar size - 200 µm
Left image: a control culture of  almost completely senescent large flattened cells.
Right image demonstrates that in the presence of  L-carnosine there are several fold more cells. Some of  the cells exposed to L-
carnosine treatment are relatively small and do not demonstrate the senescent morphology.
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Protective telomere -mediated treatment effects of  imida-
zole-containing dipeptides on dermal fibroblasts
Telomere shortening has been implicated in cellular senescence, 
which may cause certain aging phenotypes. To reveal whether 
telomere shortening is associated with chronological aging and/
or photoaging of  the skin, Sugimoto et al., [138] have measured 
telomere length in the epidermis and in the dermis from sun-pro-
tected and from sun exposed sites of  the skin. Seventy-six speci-
mens of  epidermis from sun protected sites and 24 specimens 
of  epidermis from sun exposed sites were analyzed. Sixty speci-
mens of  the dermis were also analyzed. In six cases, epidermal 
specimens from sun-protected and from sun-exposed sites of  the 
same individual were analyzed. Comparison of  telomere lengths 
revealed that the epidermis has shorter telomeres than the dermis. 
Telomere length in the epidermis and in the dermis was reduced 
with age, and average telomere shortening rates in the epidermis 
and in the dermis were 9 and 11 bp/yr, respectively. 
Unexpectedly, telomere length was not significantly different be-
tween epidermis from sun-exposed sites and from sun-protected 
sites. The authors could not show the evidence that telomere 
shortening is associated with photoaging of  the skin [138]. Re-
cent work has substantially elucidated the mechanisms of  skin 
aging and photoaging [139]. In particular, a central role for tel-
omere-based signaling can be inferred. Intrinsic aging is largely 
controlled by progressive telomere shortening, compounded by 
low grade oxidative damage to telomeres and other cellular con-
stituents, the consequence of  aerobic cellular metabolism. In sun 
exposed skin, UV irradiation also damages DNA and accelerates 
telomere shortening. Aging and photodamage appear to share a 
common final pathway that involves signaling through p53 fol-
lowing disruption of  the telomere. These telomere-initiated re-
sponses, in combination with UV-induced damage to critical regu-
latory genes, lead to the familiar picture of  "photoaging." [139].
Skin is a complex tissue composed of  two very different compart-
ments. The continuously renewing epidermis made up mostly by 
keratinocytes and the underlying matrix-rich dermis with the rest-
ing fibroblasts as its major cellular components. Both compart-
ments are tightly interconnected and a paracrine mutual interac-
tion is essential for epidermal growth, differentiation, and tissue 
homeostasis [140]. Skin aging is commonly viewed as wrinkle for-
mation, hair greying, and impaired wound healing. Nevertheless, 
the epidermis as the outermost shield needs to remain intact in 
order to guarantee an inside-out and outside-in barrier function 
throughout life time of  a human being. Furthermore, the epider-
mis is one of  the few regenerative tissues that express telomer-
ase, the ribonucleoprotein complex that can counteract telomere 
erosion, one of  the presently mostly favoured potential mech-
anisms causing cellular aging. This raises the question whether 
in the epidermis telomerase is able to counteract telomere ero-
sion and thereby to prevents a telomere-dependent aging process 
and consequently which part of  the skin is responsible for the 
most obvious changes associated with skin aging [140]. Krunic 
et al., have demonstrated [141] that telomerase is expressed in 
the epidermis in situ independent of  age but was repressed upon 
the passaging of  keratinocytes in monolayer culture. However, 
when keratinocytes were grown in organotypic cultures (OTCs), 
telomerase was re-established, indicating that telomerase activity 
is not merely proliferation-associated but is regulated in a tissue 
context-dependent manner in human keratinocytes. While not in-
ducible by growth factors, treatment with the histone deacetyla-
tion inhibitor FK228 restored telomerase activity in keratinocytes 
grown in monolayer cultures. Accordingly, CHIP analyses dem-
onstrated an acetylated, active hTERT promoter in the epidermis 
in situ and in the epidermis of  OTCs but a deacetylated, silenced 
hTERT promoter with subsequent propagation in monolayer cul-
ture suggesting that histone acetylation is part of  the regulatory 
program to guarantee hTERT expression/telomerase activity in 
the epidermis. In agreement with the loss of  telomerase activ-
ity, telomeres shortened during continuous propagation in mon-
olayer culture by an average of  approximately 70 base pairs (bp) 
per population doubling (pd). However, telomere erosion varied 
strongly between different keratinocyte strains and even between 
individual cells within the same culture, thereby arguing against a 
defined rate of  telomere loss per replication cycle. In the epider-
mis in situ, as determined from early-passage keratinocytes and 
tissue sections from different age donors, the authors calculated 
a telomere loss of  only approximately 25 bp per year [141]. Since 
Krunic et al., determined the same rate for the non-regenerating 
melanocytes and dermal fibroblasts, their data suggest that in hu-
man epidermis telomerase is a protective mechanism against ex-
cessive telomere loss during the life-long regeneration [141]. The 
reason for the sustained expression of  telomerase activity in the 
epidermis is that the formation of  a well structured epidermis 
strictly depends on a tight balance between proliferation and dif-
ferentiation [142]. Accordingly, telomerase, which is restricted to 
proliferating cells, is downregulated with differentiation. It is un-
clear, however, whether this inhibition is essential to or only a 
consequence of  the differentiation process. By studying different 
variants of  the HaCaT skin keratinocytes Cerezo et al., [142] dem-
onstrated that constitutive overexpression of  human telomerase 
reverse transcriptase (hTERT) in HaCaT-TERT cells (lacking its 
own differentiation-sensitive promoter) and constitutive expres-
sion of  the c-myc gene in HaCaT-myc cells caused increased pro-
liferation in conventional cultures; however, this proliferative ad-
vantage was not maintained in tissue-like organotypic cocultures. 
Despite reduced stratification, HaCaT-myc cells were still able to 
develop a fully differentiated epithelium. HaCaT-TERT cultures, 
on the other hand, expressed all markers of  early but not of  ter-
minal differentiation. The failure to differentiate terminally was 
observed in hTERT mass cultures and individual clones and cor-
related with an intense nuclear hTERT staining of  the uppermost 
cells of  the HaCaT-TERT epithelia. Thus, the published data sug-
gest that constitutive overexpression of  hTERT does not inter-
fere with epidermal differentiation per se but blocks the terminal 
stage of  differentiation and therefore indicates that hTERT/tel-
omerase plays an active part in the regulatory pathway of  epider-
mal differentiation [142].
Most human cells lack sufficient telomerase to maintain telom-
eres, hence these genetic elements shorten with time and stress, 
contributing to aging and disease. In January, 2007, a commercial 
health maintenance program, PattonProtocol-1, was launched 
that included a natural product-derived telomerase activator (TA-
65((R)), 10-50 mg daily), a comprehensive dietary supplement 
pack, and physician counseling/laboratory tests at baseline and 
every 3-6 months thereafter [143]. We report here analysis of  the 
first years of  data focusing on the protection of  telomeres in fi-
broblasts system using imidazole-containing dipeptides.
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In the recent work, the authors studied the effect of  carnosine on 
a human fetal lung fibroblast strain (HPF), which was either kept 
in a continuously proliferating or proliferation-inhibited state. 
The results indicate that carnosine can reduce telomere short-
ening rate possibly by protecting telomere from damage [144]. 
Based on our own studies, we have suggested that the reduction in 
telomere shortening rate and damages in telomeric DNA made an 
important contribution to the life-extension effect of  carnosine 
and carcinine [42, 43].
Cumulatively, in this article we propose that patented specific oral 
formulations of  non-hydrolized carnosine and carcinine provide 
a powerful tool for targeted inhibition of  cumulative oxidative 
stress and inflammation associated with telomere shortening 
and senescent phenotype of  skin fibroblasts in skin aging and 
age-related diseases and during smoking behavior (Figures 7,8 ) 
[42-44, 89]. This product concept implements the potential role 
of  the new nutritional strategy on redox balance in age-related 
eye diseases and detail how the synergism and interaction of  im-
idazole-containing amino acid-based compounds (nonhydrolized 
L-carnosine, histidine), chaperone agents (such as, L-carnosine, 
D-pantethine), glutathione-boosting agents (N-acetylcysteine, 
vitamin E, methionine), and plays key roles in the function and 
maintenance of  the redox systems in the skin fibroblasts and tis-
sues during aging and in the treatment of  human skin disease. 
The recently published study investigates whether an orally active 
non-hydrolized forms of  carnosine or carcinine have skin protec-
tive and beautification properties in cases of  skin aging and clini-
cal diabetic skin manifestations. Treatment with non-hydrolized 
forms of  carnosine and carcinine of  patients was accompanied 
by improvement in skin appearance through the initially proposed 
transglycation and universal antioxidant mechanisms of  action 
[126]. In the present study, more importantly, the oral formulation 
of  non-hydrolized carnosine is proposed to ameliorate the tel-
omere and telomerase dysfunctions, including telomeres-medi-
ated effects in skin fibroblasts with senescent phenotype of  the 
adult patients. Pharmacological manipulation of  those signaling 
omponents may lead to the prevention and treatment of  skin 
aging and cancer induced by chronic solar exposure. Telomere 
shortening has not only been linked to aging but also to several 
age associated diseases, including tumorigenesis, coronary artery 
disease, and heart failure. In the current review, we discuss the 
role of  telomere biology in relation to skin aging and aging as-
sociated diseases.
Thus, the orally active cellular system of  imidazole-containing di-
peptide based compounds (non-hydrolized carnosine, carcinine) 
protect from telomere attrition and are acting as telomerase en-
hancer as a part of  the health maintenance anti-aging program, 
provide a new option for the clinical treatment of  intrinsic skin 
aging, photoaging and skin diabetic lesions [42-44, 89, 126].
Conclusion
Oxidative damage is the primary cause of  skin aging. Skin care 
products are numerous and overwhelming, yet there is certain 
similarity among different formulations. Moisturizers are ubiq-
uitous and the presence of  particular added ingredients usually 
supports specific marketing claims [145]. It is believed that oxida-
tive stress is caused by an imbalance between the production of  
reactive oxygen and a biological system's ability to neutralize the 
reactive intermediates. Oxidative damage occurs because of  both 
intrinsic and extrinsic mechanisms. Together, intrinsic and extrin-
sic damage are the primary causes of  skin aging. The skin uses a 
series of  intrinsic antioxidants to protect itself  from free radical 
damage. Naturally occurring extrinsic antioxidants have also been 
widely shown to offset and alleviate these changes [146].
Oral dosage forms of  non-hydrolized carnosine or carcinine 
induce cellular responses in human skin fibroblasts through the 
telomere-mediated pathway and redox signaling, supporting the 
view that carnosine or related imidazole-containing dipeptide 
based compound-induced hormetic stimulation of  cellular anti-
oxidant defenses can be a useful approach toward anti-aging in-
tervention to the skin. The present study extends our previous 
findings and demonstrates that oral application of  non-hydrolized 
forms of  carnosine or carcinine in human volunteers significantly 
increases the antioxidative potential of  skin biosurface, thus high-
lighting the effectiveness of  a natural antioxidant biotechnology 
in the anti-aging management of  skin.
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